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During pregnancy, the mother must adapt her body systems to support nutrient and
oxygen supply for growth of the baby in utero and during the subsequent lactation.
These include changes in the cardiovascular, pulmonary, immune and metabolic systems
of the mother. Failure to appropriately adjust maternal physiology to the pregnant state
may result in pregnancy complications, including gestational diabetes and abnormal
birth weight, which can further lead to a range of medically significant complications
for the mother and baby. The placenta, which forms the functional interface separating
the maternal and fetal circulations, is important for mediating adaptations in maternal
physiology. It secretes a plethora of hormones into the maternal circulation which
modulate her physiology and transfers the oxygen and nutrients available to the fetus
for growth. Among these placental hormones, the prolactin-growth hormone family,
steroids and neuropeptides play critical roles in drivingmaternal physiological adaptations
during pregnancy. This review examines the changes that occur in maternal physiology
in response to pregnancy and the significance of placental hormone production
in mediating such changes.
Keywords: pregnancy, placenta, hormones, maternal adaptations, metabolism, fetal growth, endocrine,
cardiovascular
INTRODUCTION
Pregnancy is a dynamic and precisely coordinated process involving systemic and local changes
in the mother that support the supply of nutrients and oxygen to the baby for growth in utero
and in the subsequent lactation. Inappropriate adaptation of maternal physiology may lead to
complications of pregnancy, such as gestational diabetes, preeclampsia, fetal growth restriction,
fetal overgrowth and pre-term birth; which can have immediate consequences for fetal and
maternal health. Furthermore, these pregnancy complications can also lead to long-term health
consequences for the mother and infant. Altered fetal growth is associated with an increased risk
of the offspring developing obesity, type-2 diabetes and cardiovascular disease in adulthood (Hales
and Barker, 2001; Barker, 2004; Fowden et al., 2006). Moreover, women who develop gestational
diabetes or preeclampsia aremore likely to develop type-2 diabetes or cardiovascular disease in later
life (Kim et al., 2002; Petry et al., 2007). Maternal adaptations to pregnancy are largely mediated by
the placenta; the functional interface between the mother and fetus that secretes hormones and
growth factors into the mother with physiological effects. This review aims to provide an overview
of the physiological changes that occur in the mother in response to pregnancy and to discuss the
role of key placental hormones in mediating such adaptations. In particular, this review focuses
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on the importance of the prolactin-growth hormone family
(e.g., prolactin, placental lactogen and growth hormone), steroids
(estrogens and progesterone) and neuropeptides (serotonin,
melatonin and oxytocin) in adaptations of maternal physiology
during pregnancy. Where possible, this review draws upon
findings in women and animal models, including rodents
and sheep. However, differences exist between species in the
specific hormones produced by the placenta, the access of
these hormones to the maternal circulation, and the relative
proportion of conceptus mass to maternal size (hence constraint
on the mother to provide resources for fetal growth; Haig, 2008;
Carter, 2012; Fowden and Moore, 2012). Where such differences
between species exist, these have been highlighted and discussed
as necessary in the relevant sections. Nevertheless, although
some effects described may not be applicable to all species, the
different animal models of pregnancy still provide novel insight
into the fundamental mechanisms of maternal adaptation during
gestation.
ADAPTATIONS IN MATERNAL
PHYSIOLOGY DURING PREGNANCY AND
LACTATION
Most tissues and organs in the mother respond to the pregnant
state. Changes include alterations in size, morphology, function
and responsiveness of tissues and organs to hormonal and
metabolic cues. These changes arise in the cardiovascular,
pulmonary, immune, and metabolic systems of the mother
(Figure 1). Some of these changes are seen from very early
in pregnancy, prior to the establishment of a fully functional
placenta, highlighting that non-placental factors may also be
important (Paller et al., 1989; Drynda et al., 2015). The specific
nature of changes in maternal physiology depends on the stage
of the pregnancy and appears to track with alterations in the
metabolic requirements of the mother versus the developing
fetus.
Alterations in the maternal cardiovascular system begin very
early in gestation (Chapman et al., 1998) and ultimately lead to
systemic vasodilation and increased blood perfusion of maternal
organs, including the gravid uterus. Systemic vascular resistance
is reduced by 25–30% and accompanied by a 40% increase in
cardiac output during human pregnancy; while in mice, blood
pressure decreases by 15% and cardiac output is increased by
48% (Bader et al., 1955; Kulandavelu et al., 2006; Soma-Pillay
et al., 2016). Renal blood flow and glomerular filtration rates are
also increased (Davison and Dunlop, 1980; Soma-Pillay et al.,
2016). The renin-angiotensin-aldosterone system (RAAS) which
is a major determinant for sodium balance during gestation, is
progressively upregulated toward term with associated plasma
volume expansion (Elsheikh et al., 2001; Tkachenko et al.,
2014). This rise in blood volume, which is required to cope
with the oxygen requirements of the maternal organs and the
conceptus growth, plateaus by the late gestation, resulting in
an increase in total blood volume by approximately 30% at the
end of pregnancy (Chang and Streitman, 2012). There is also an
increase in the numbers of red blood cells in the mother during
pregnancy, due to proliferation of erythroid progenitors in the
spleen (Bustamante et al., 2008). Pulmonary function is also
altered and encompasses changes in ventilation rates and blood
gases. For instance, lung tidal volume and minute ventilation
increases by 30–50% (Hegewald and Crapo, 2011). As a result
of increased oxygen consumption during hyperventilation, there
is greater carbon dioxide production, which leads to chronic
respiratory alkalosis that is compensated by an increased renal
excretion of bicarbonate (Weinberger et al., 1980). Overall,
these adaptations ensure the well-being of the mother, while
also providing an adequate blood flow to the placenta for fetal
nutrition, oxygenation and maturation.
There are also alterations inmaternalmetabolic and endocrine
state during gestation. In early pregnancy, the maternal
pancreatic β-cell mass expands due to both hyperplasia and
hypertrophy of islets, which for example in rats, results in
a >50% increase (Ackermann and Gannon, 2007; Rieck and
Kaestner, 2010). The threshold for glucose-stimulated insulin
production is also lowered and maternal circulating insulin
concentration is greater compared to the non-pregnant state. In
early pregnancy, when fetal demands are relatively low, whole
body maternal insulin sensitivity is unchanged or increased
and there is accumulation of energy reserves in the mother.
In particular, early pregnancy is associated with adipocyte
hypertrophy, increased lipogenesis and lipid storage and relates
to improved insulin sensitivity of white adipose tissue in the
mother (Hadden and Mclaughlin, 2009; Mcilvride et al., 2017).
Interestingly, in pregnant mice, brown adipose stores of the
dam also switch to a white adipose tissue-like phenotype in
early gestation (Mcilvride et al., 2017). Additionally, glycogen
accumulates in the liver, which also increases in size from early
gestation (Bustamante et al., 2010). In contrast, late pregnancy is
associated with diminishedmaternal tissue insulin sensitivity and
a concomitant increase in lipolysis and hepatic gluconeogenesis
(Freemark et al., 2002; Lain and Catalano, 2007; Musial et al.,
2016). Despite the pregnancy-related rise in leptin and insulin
concentrations, maternal appetite increases in pregnancy (Villar
et al., 1992; Douglas et al., 2007; Hadden and Mclaughlin, 2009;
Díaz et al., 2014). Together, these metabolic and endocrine
alterations increase lipid and glucose availability for the rapidly
growing fetus in late gestation. Intriguingly in rodents, whole
body responsiveness to insulin starts to improve near term,
which may be important for conserving nutrients for maternal
use, as parturition and lactation approach (Musial et al., 2016).
There are also notable changes in maternal bone metabolism
during pregnancy. In particular, intestinal calcium absorption
is enhanced in the mother during pregnancy via upregulation
of 1,25-dihydroxyvitamin D levels, improved renal conservation
and increased calcium mobilization from the maternal skeleton
(Hellmeyer et al., 2006). These processes support the supply of
calcium for the formation, growth and mineralization of the fetal
skeleton (King, 2000; Kalkwarf and Specker, 2002).
The immune system of the mother during pregnancy is tightly
regulated to prevent an unwanted immune response against the
paternal antigens present in the developing conceptus (Racicot
et al., 2014; Groen et al., 2015; Zöllner et al., 2017). As gestation
progresses, there is suppression of the pro-inflammatory Th1
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FIGURE 1 | Schematic diagram highlighting the main physiological modifications in the maternal physiology in response to pregnancy. Many of the changes
described in the figure for women during pregnancy also occur in other species, including mice. Respiratory system (Macrae and Palavradji, 1967; Weinberger et al.,
1980; Contreras et al., 1991; Hegewald and Crapo, 2011; Frise et al., 2013; Lomauro and Aliverti, 2015; Soma-Pillay et al., 2016); cardiovascular system (Adamova
et al., 2009; Li et al., 2012; Pieper, 2015; Soma-Pillay et al., 2016); hematological system (Shakhmatova et al., 2000; Chang and Streitman, 2012; Rodger et al.,
2015; Soma-Pillay et al., 2016); spleen (Maroni and De Sousa, 1973; Sasaki et al., 1981; Norton et al., 2009); renal system (Davison and Dunlop, 1980; Atherton
et al., 1982; Krutzén et al., 1992; Elsheikh et al., 2001; Cheung and Lafayette, 2013; Lumbers and Pringle, 2014; Pieper, 2015; Soma-Pillay et al., 2016); pancreas
(Ziegler et al., 1985; Ernst et al., 2011; Ohara-Imaizumi et al., 2013; Baeyens et al., 2016); adipose tissue (Catalano et al., 2006; Hauguel-De Mouzon et al., 2006;
Lain and Catalano, 2007; Nien et al., 2007; Hadden and Mclaughlin, 2009; Valsamakis et al., 2010; Musial et al., 2016); skeletal muscle (Alperin et al., 2015, 2016;
Musial et al., 2016); bone (Shahtaheri et al., 1999; Ulrich et al., 2003; Hellmeyer et al., 2006; Salles, 2016); digestive tract (Everson, 1992; Fudge and Kovacs, 2010;
Pieper, 2015); liver (Munnell and Taylor, 1947; Van Bodegraven et al., 1998; Lain and Catalano, 2007; Bacq, 2013); mammary tissue (Elling and Powell, 1997; Neville
et al., 2002; Sternlicht, 2006; Pang and Hartmann, 2007); immune system (Clarke and Kendall, 1994; Kendall and Clarke, 2000; Veenstra Van Nieuwenhoven et al.,
2002; Norton et al., 2009; Mor and Cardenas, 2010; Saito et al., 2010; Racicot et al., 2014; Groen et al., 2015; Zöllner et al., 2017; Edey et al., 2018); nervous system
(Shingo et al., 2003; Gregg, 2009; Roos et al., 2011; Hoekzema et al., 2017).
type of immunity and a shift toward a more anti-inflammatory,
Th2 immune state in the mother (Saito et al., 2010), which
supports fetal growth and maternal well-being (Mor and
Cardenas, 2010). In particular, the total abundance of circulating
leukocytes, monocytes, granulocytes and T lymphocytes increase
in the mother in response to pregnancy (Groen et al., 2015).
However, expression of major histocompatibility complex class
II by circulating monocytes is reduced in the mother, which
would decrease antigen presentation and stimulation of T cells
during pregnancy and prevent the maternal immune system
from mounting an unwanted response against fetal antigens
(Groen et al., 2015). The total number of circulating natural
killer cells and secretion of pro-inflammatory cytokines (IFN-
gamma) is also reduced in the pregnant state (Veenstra Van
Nieuwenhoven et al., 2002). However, close to parturition, the
maternal immune system shifts to a pro-inflammatory state,
particularly locally within the uterus, to promote labor (Mor
and Cardenas, 2010; Edey et al., 2018). There are also specific
changes in the numbers of different leukocyte populations in
the maternal thymus and spleen during pregnancy (Clarke and
Kendall, 1994; Kendall and Clarke, 2000; Norton et al., 2009).
The spleen, which also has functions in hematopoiesis, enlarges
due to an expansion of the splenic red pulp during pregnancy
(Maroni and De Sousa, 1973; Norton et al., 2009). Neurological
changes must also occur during pregnancy to increase maternal
nursing behavior and enable the mother to properly care for her
newborn infant (Bridges et al., 1997; Bridges, 2015; Kim, 2016;
Kim et al., 2016). For instance, there is increased activation of
the prefrontal cortex and neurogenesis of the forebrain olfactory
bulb (Shingo et al., 2003), which are important in regulating
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behavior. In addition, formation of lobulo-alveolar units in the
mammary gland commences during pregnancy, in preparation
for lactational support of the neonate.




The placenta is a highly active endocrine organ during
gestation; secreting a variety of hormones with physiological
effects in the mother. Placental hormones include members of
the prolactin and growth hormone family, steroid hormones
and neuroactive hormones. The function of these hormones
in driving physiological changes during pregnancy has been
assessed in twomain ways. First, the expression and activity of the
hormones have been manipulated in vivo by either exogenously
administering or genetically manipulating the expression of
hormones and hormone receptors to study the physiological
consequences for the animal. Secondly, hormones have been
manipulated similarly in cultured cells and tissue explants to
inform on the cellular and molecular mechanisms by which they
modulate function. The effects of hormones in non-pregnant
animals have been included as they provide information on the
baseline of physiological changes that occur in the absence of
hormone expression/activity, which is especially important in the
case of some placental-derived hormones, where analyses in the
pregnant state have not been conducted.
Prolactin (PRL)-Growth Hormone (GH)
Family
The PRL-GH family is one of the main families of hormones
secreted by the placenta during gestation. Members of this family
consist of prolactin (PRL) (Handwerger et al., 1992), placental
lactogens (PLs) (Wiemers et al., 2003), PRL-like hormones
(Wiemers et al., 2003), proliferins (PLF) (Lee et al., 1988),
proliferin-related proteins (PRP) (Jackson et al., 1994) and
growth hormone (GH). Between mammalian species, there are
differences in the number and type of family members expressed
by the placenta [reviewed elsewhere (Linzer and Fisher, 1999;
Soares, 2004; Soares et al., 2007)]. For instance, in the mouse
and rat, the placenta expresses all these members except for PRL
and GH whereas the human placenta only expresses GH and PL
genes. In mice and rats, expression of the individual PRL-GH
family members vary spatially and temporally in the placenta
(Dai et al., 2002; Simmons et al., 2008; Urbanek et al., 2015).
The anterior pituitary also produces PRL and GH; however
this is diminished by mid-pregnancy, when placental hormone
production predominates (Bridges, 2015). In several species
including rodents and humans, PRL is additionally produced
by the decidua during pregnancy. The family members share
structural similarity to one another and may bind, with varying
affinity to PRL and GH receptors (PRLR and GHR, respectively),
which are widely expressed by tissues in the body (Haig, 2008;
Trott et al., 2008; Ben-Jonathan andHugo, 2015). As the PRL-GH
members also exert similar functions, these have been presented
in a grouped fashion in the text and tables (Tables 1, 2). However,
where possible, the roles of individual family members of the
PRL-GH in physiological changes have been described.
Studies performed both in vivo and in vitro support a
role for the PRL-GH family in mediating maternal metabolic
adaptations to pregnancy (Tables 1, 2). PRL, PRL-like proteins
and PL, principally via the PRL receptor, induce β-cell mass
expansion by both increasing β-cell proliferation and reducing
apoptosis of islets in vivo and in vitro (Table 2; PRL/PL/GH;
Brelje et al., 1993; Huang et al., 2009). PRL and PL also
increase insulin secretion during pregnancy, particularly in
response to glucose, by enhancing the expression of glucose
sensors (glucokinase, hexokinase and glucose transporter-2) and
activating the serotonin biosynthesis pathway in pancreatic islets
(Table 2; PRL/PL/GH; Nielsen, 1982; Brelje et al., 1989, 1993;
Weinhaus et al., 1996; Sorenson and Brelje, 1997; Arumugam
et al., 2014). Moreover, PL protects β-cells against streptozotocin-
induced cell death in mice (Fujinaka et al., 2004). GH may
also be important for modulating pancreatic insulin production
(Billestrup and Nielsen, 1991; Brelje et al., 1993). However,
GH from the placenta appears to be primarily important in
the acquisition of insulin resistance and shifting metabolic fuel
use from glucose to lipid in the mother during pregnancy
(Table 1; PRL/PL/GH; Horber and Haymond, 1990; Goodman
et al., 1991; Galosy and Talamantes, 1995; Barbour et al., 2002;
Dominici et al., 2005; Boparai et al., 2010; Liao et al., 2016b;
Sairenji et al., 2017). Placental GH reduces insulin receptor
expression and signaling, as well as, diminishes the abundance
of the insulin-sensitive glucose-transporter, GLUT-4, in the
skeletal muscle (Barbour et al., 2004; Kirwan et al., 2004).
Insulin receptor abundance and signaling in the liver is also
reduced in response to increased GH abundance in transgenic
mice (Dominici et al., 1999). In white adipose tissue, GH also
disrupts the insulin signaling pathway, and inhibits insulin action
on glucose uptake and lipid accumulation (Del Rincon et al.,
2007). In part, the effects of GH may be mediated through
insulin-like growth factor-1 (IGF1), which is primarily secreted
from the liver in response to GH and exerts lipolytic effects
during pregnancy (Randle, 1998; Sferruzzi-Perri et al., 2006;
Del Rincon et al., 2007). Insulin-like growth factor-2 (IGF2),
which is not directly regulated by GH, but is secreted by the
placenta is also important for modulating the sensitivity of β
cells to glucose (Tables 1, 2; IGF2; Casellas et al., 2015; Modi
et al., 2015) and maternal insulin and glucose concentrations
during pregnancy (Petry et al., 2010; Sferruzzi-Perri et al., 2011).
Polymorphisms/mutations in the PRL-GH family of genes and
receptors have been reported in human pregnancies associated
with gestational diabetes and fetal growth restriction (Rygaard
et al., 1998; Le et al., 2013). Moreover, loss of PRLR signaling
in β-cells causes gestational diabetes mellitus (GDM) in mice
(Banerjee et al., 2016). Taken together, the production of PRL-GH
family of hormones by the placenta appears to be important in
regulating both insulin production and sensitivity of the mother
in response to pregnancy.
The PRL-GH family is also implicated in the regulation
of appetite and body weight. For instance, exogenous PRL
increases food intake through inhibiting the action of leptin
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TABLE 1 | Effects of the prolactin-growth hormone family in vivo.
Hormone Expression
level







Prl knockout Prl−/− (mouse):
↓ fertility; blood prolactin; mammary gland development (ductal branching,
alveolar budding); oocyte maturation
↔ weight; body composition; blood lipids, adiponectin, leptin, glucose tolerance
Horseman et al., 1997;
Gallego et al., 2001;
Lapensee et al., 2006
Prl receptor knockout Prlr−/− (mouse):
↓ fertility; weight; abdominal fat content; glucose tolerance; pancreatic β cell
mass; GSIS; blood leptin, progesterone
↑ blood glucose and prolactin
Freemark et al., 2001,
2002; Rawn et al., 2015
Heterozygous Prl receptor knockout Prlr+/− (mouse):
↔ body weight; glucose and insulin tolerance; GSIS; blood insulin and glucose
Binart et al., 2000
GH receptor knockout GHR/BP−/− (human/mouse):
↓ body size (weight and height); postnatal growth rate; blood glucose and IGFI;
sexual maturation
↑ proportional dwarfism (human), abdominal adiposity; blood GH
Zhou et al., 1997
Injection with GHRH antisera (rat):
↓ growth rate; blood growth hormone
Vaccarello et al., 1993
GHRH knockout GHRH −/− (mouse):
↓weight, blood and liver IGF1, pituitary growth hormone; pituitary size; adipose
tissue expression of adiponectin and visfatin; hypothalamic expression of CRH,
norepinephrine; anxiety and depression related behavior
↑adiposity; food intake, blood adiponectin, ghrelin, hypothalamic expression of
AgRP, NPY; exploratory activity
↔ blood leptin




Heterozygous PRL receptor knockout Prlr+/− (mouse):
↓ pup-induced maternal behavior; post-partum nurturing behavior (pup retrieval);
glucose tolerance; blood insulin; GSIS, pancreatic β cell proliferation and mass;
olfactory bulb interneuron proliferation; mammary gland differentiation; milk
protein expression (β-casein, whey acidic protein)
↑ blood glucose, serum metabolites
↔ body weight; insulin tolerance; blood pressure; fertility; pup weight
Horseman et al., 1997;
Lucas et al., 1998;
Huang et al., 2009; Rawn
et al., 2015
Bromocriptine inhibition of Prl secretion (mouse):
↓ milk production (↓pSTAT5)
↑ Cldn3 and Cldn4
Weinhaus et al., 1996
GH knockout GHR/BP−/− (mouse):
↓ lactation (mouse)





Wennbo et al., 1997
Exogenous PRL (rats):
↓ GSIS
↑ food intake (↓ability of leptin to suppress food intake), fat deposition, blood
insulin, β cell coupling
Sorenson et al., 1987;
Ladyman et al., 2010
Exogenous GH (human):
↓ insulin sensitivity





↑ mammary gland lymphocytes
Dill and Walker, 2017
PLP-E overexpression (mouse):
↑ thrombocytopenia recovery; neutropenia recovery
↔ platelet, erythrocyte, total white blood cell levels
Zhou et al., 2005
Pancreatic islet-specific PL-I overexpression (mouse):
↓ blood glucose
↑ pancreatic β cell mass (↑islet proliferation and size) and insulin content; blood
insulin
↔ GSIS
Vasavada et al., 2000
Exogenous PRL (ovariectomized rat):
↑ induction of maternal behavior (nurturing, retrieval, nursing and crouching)
Sairenji et al., 2017
(Continued)
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TABLE 1 | Continued
Hormone Expression
level
In vivo effects References
Transgenic human GH expression (mouse):
↓ adiposity; insulin sensitivity; blood FFA
↑ body weight; bone density; GSIS; blood insulin and IGF1
↔ blood glucose (fasting and glucose post challenge)
Boparai et al., 2010
Exogenous GH pulsatile variant (mouse):
↓ insulin sensitivity; blood IGF1
↑ body weight (liver, kidney, spleen); blood insulin; hepatic Ghr/Ghbp
↔ food intake, adiposity, heart weight, blood glucose
Liao et al., 2016a
Exogenous GH (ovariectomized rat):
↑ induction of maternal behavior (pup retrieval)





↓ development of corpus luteum
↑ B and T cells, neutrophils and macrophage recruitment to the mammary gland









↓ insulin sensitivity, hepatic Glut4
↑ blood insulin and adiposity (perirenal and gonadal), hepatic Ghr/Ghbp
↔ body weight, food intake, blood IGF1
Liao et al., 2016b
Exogenous GHRH (cow):
↑ blood IGF1, somatomedin C, glucose, tri-iodothyronine (T3), insulin, NEFA;
mean and pulsatile release of growth hormone; milk production; milk fat, protein,
lactose yields; feed efficiency (milk production relative to food intake)
Hart et al., 1985; Enright
et al., 1986, 1989;
Pelletier et al., 1987;
Lapierre et al., 1988;
Abribat et al., 1990;
Blanchard et al., 1991
Exogenous GHRH via injected plasmid (cow):
↓ maternal mortality; hoof pathology
↑ number of T lymphocytes; body weight; health status (body condition scores)
↔ blood glucose or insulin
Brown P. A. et al., 2004
Exogenous GHRH (sheep):
↓ blood urea
↑ blood GH, IGF1, insulin, glucose, FFA; milk yield and fat concentration
Hart et al., 1985
Exogenous GHRH or analog (pig):
↑ gestation length; pregnancy weight gain; blood GH; blood and milk IGF1,
offspring livebirths, weight and survival
Farmer et al., 1991,
1992, 1996; Etienne






Pancreatic β-cell specific Igf2 inactivation (mouse):
↓ GSIS (aged female)
↑ insulin sensitivity
↔ glucose tolerance
Modi et al., 2015
Pancreatic β-cell specific Igf2 knockout with high-fat diet (mouse):
↓ GSIS; pancreatic β-cell mass (only in females)




Placental-specific Igf2 knockout Igf2P0 (mouse):
↓ blood alpha-amino nitrogen; fetal and placental weight
↑ body weight; blood insulin, cortisol, leptin
↔ blood glucose
Mikaelsson et al., 2013
High Non-
pregnant






↑ visceral tissue amino acid uptake, fetal weight; placental structural and
functional capacity
↔ lean mass; adiposity; blood glucose, alpha-amino nitrogen, FFA, triglycerides
and cholesterol
AgRP, Agouti-related peptide; CRH, Corticotropin-releasing hormone; FFA, Free fatty acids; GSIS, Glucose-stimulated insulin secretion; NEFA, Non-esterified fatty acids; NPY,
Neuropeptide Y.
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TABLE 2 | Effects of the prolactin-growth hormone family in vitro.
Hormones Expression
level





Low siRNA knockdown of PRL receptor (rat pancreatic β-cells):
↓ DNA synthesis (↓ cyclin B2 and D2, IRS-2, Tph1)
↑ apoptosis (↓anti-apoptotic proteins PTTG1, p21 and BCL6)
↔ β cell replication or survival related genes (p18, p19, Cyclin D3, CDK2, CDK4, CDK6,
IGF2, BAX, or TLR4)
Arumugam et al., 2014
siRNA knockdown of GH (hen granulosa cells primary culture):
↓ proliferation
Ahumada-Solórzano et al., 2016
High Exogenous PRL, PLP, GH (human, rat and mouse islets):
↓ apoptosis (↑anti- apoptotic proteins; p21 and BCL6)
↑ β-cell mass; GSIS; DNA synthesis, β-cell replication or survival related genes (cyclins A2,
B1, B2 and D2, IRS-2, Tph1, FoxM1, BCLxL and PTTG1); insulin secretion and glucose
oxidation (only PRL;↑glucokinase, hexokinase and GLUT2 expression); serotonin
biosynthesis (Tph1, Tph2, Jak2, STAT5)
↔ β cell replication or survival related genes (p18, p19, Cyclin D3, CDK2, CDK4, CDK6,
IGF2, BAX, or TLR4).
Nielsen, 1982; Brelje et al., 1989,
1993; Weinhaus et al., 1996;
Sorenson and Brelje, 1997;
Arumugam et al., 2014
Exogenous PRL (mouse alveolar mammary epithelial cells):
↓ milk protein expression (β-casein)
↑ leaky tight junctions (↓Tj transmembrane proteins: Cldn3, Cldn4)
Kobayashi et al., 2016
Exogenous PRL (human fetal membranes+LPS):
↓ TNF-α, IL-1β
↔ IL-6, IL-10
Flores-Espinosa et al., 2017
Exogenous PRL (rat uterine stromal cells):
↓ decidualization (PGE2, PGF2α); cytolytic activity
↔ cell viability; proliferation
Prigent-Tessier et al., 1996
Exogenous PL (mouse ovarian cells):
↑ progesterone secretion
Galosy and Talamantes, 1995
Exogenous PRL (rat uterine NK cells):
↓ cytolytic activity
↔ cell viability; proliferation
Müller et al., 1999
PLPE transfection (human and murine erythroid cells):
↑ proliferation; differentiation (hemoglobin production)
Bittorf et al., 2000
Exogenous PLF (bovine capillary endothelial cells):
↑ angiogenesis- endothelial cell migration (through MAPK activation and IGF-II/mannose
6-phosphate receptor interaction)
Groskopf et al., 1997
PLP-E/F exogenous (mouse bone marrow):
↑ megakaryocyte differentiation, progenitor growth (colony formation)
Zhou et al., 2002
Exogenous PLF (mouse neuroblastoma cells):
↑ microvilli formation; proliferation
Wang et al., 2006
Exogenous GH (hen granulosa cells primary culture):
↑ proliferation; IGF1 secretion
Ahumada-Solórzano et al., 2016
Exogenous GHRH (sheep and rat pituitary cells):
↑ GH secretion; IGF1 secretion
Blanchard et al., 1991
Exogenous GH (rat ovarian granulosa cells):
↓ LH-stimulated progesterone production
↑ progesterone production; cAMP accumulation
Apa et al., 1995
Insulin-like growth
factor 2 (Igf2)
Low Treatment with Igf2 mutant + prolactin (bovine capillary endothelial cells):
↓ motility; MAPK activity
Groskopf et al., 1997
IGF2R siRNA knockdown (BeWo and human placental villous explants):
↓ apoptosis
↑ IGF2-stimulated mitosis
Harris et al., 2011
IGF2 knockdown (human hemangioma stem cells):
↓ cell differentiation; leptin induction
↔ proliferation
Kleiman et al., 2013
High Exogenous (human endothelial cells):
↑ migration; angiogenesis
Lee et al., 2000
Exogenous (chick chorioallantoic membrane):
↑ angiogenic activity; migration
Bae et al., 1998
(Continued)
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TABLE 2 | Continued
Hormones Expression
level
In vitro effects References
Exogenous (human keratinocyte cell line, human liver carcinoma cell line):
↑ VEGF
Bae et al., 1998
Adenoviral-mediated overexpression (mouse pancreatic β cells):
↓ β cell differentiation; islet function (↑ glucose intolerance and↓ insulin release)
Casellas et al., 2015
Exogenous (bovine granulosa cells):
↑ proliferation; estradiol and progesterone production; aromatase (CYP19A1) mRNA
Spicer and Aad, 2007
Exogenous (mouse primary hepatocytes):
↑ proliferation
Bae et al., 1998
BAX, BCL2 associated X; CDK, Cyclin dependent kinases; GSIS, Glucose-stimulated insulin secretion; IRS2, Insulin receptor substrate 2; LPS, Lipopolysaccharide; MAPK, Mitogen-
activated protein kinase; PGE, Prostaglandin E synthase; PGF2α, Prostaglandin F2α; PTTG1, Pituitary tumor-transforming 1; siRNA, short interfering RNA; TLR4, Toll-like receptor;
VEGF, Vascular endothelial growth factor.
in non-pregnant rats (Table 1; PRL/PL/GH; Sorenson et al.,
1987; Farmer et al., 1991, 1992; Ladyman et al., 2010). In
contrast, GH appears to decrease food intake in rodents through
reducing ghrelin production and hypothalamic expression of
appetite-stimulating neuropeptides, AgRP and NPY (Table 1;
PRL/PL/GH; Farmer et al., 1991, 1992). In non-pregnant animals,
GH is important for controlling body weight and composition
(such as adiposity; Farmer et al., 1991, 1992; Zhou et al., 1997).
However, in pregnancy, exogenous GH or GH releasing hormone
(GHRH) does not appear to affect maternal weight gain in mice,
although increases it in pigs (Table 1; PRL/PL/GH; Brown et al.,
2012). The effect of PRL on weight gain and body adiposity is
even less clear; with both no effect and an increase reported for
non-pregnant and pregnant rodents.
The PRL-GH family also plays an important role in lactation
and maternal behavior. In mice, a deficiency in PRLR or
inhibition of PRL secretion in vivo compromises mammary gland
development, differentiation and milk production; the latter of
which is associated with loss of STAT5 signaling and fewer leaky
tight junctions (Table 1; PRL/PL/GH; Weinhaus et al., 1996;
Zhou et al., 1997). In contrast, exogenous GHRH in sheep and
cows increases mammary gland milk production (Hart et al.,
1985; Enright et al., 1988). There is also evidence that PRL
induces maternal behaviors, such as nurturing, nursing and
pup retrieval in non-pregnant rodents (Table 1; PRL/PL/GH;
Bridges and Millard, 1988). Taken together, members of the
PRL-GH family appear to promote changes in maternal glucose
metabolism, behavior and mammary gland function which are
expected to be important for supporting the growth of offspring
during pregnancy and lactation.
Steroid Hormones
The placenta is a primary source of steroid hormones during
pregnancy. Placental steroid hormones include estrogens and
progesterone (Costa, 2016; Edey et al., 2018). In species like
rodents, the corpus luteum continues to contribute to the
circulating pool of steroid hormones during pregnancy, whereas
in other species such as humans and ruminants, the placenta
serves as the main source (Costa, 2016). Physiological effects of
progesterone are mediated predominately by nuclear receptors
(PR-A, PR-B) although membrane bound-type receptors (mPR)
enable non-genomic actions. Steroid hormones are implicated
in pregnancy complications such as gestational diabetes and
preeclampsia. High progesterone and estrogen concentrations
have been reported for women with gestational diabetes
(Branisteanu and Mathieu, 2003; Qi et al., 2017). Moreover,
placental estrogen and progesterone levels are reduced in
preeclamptic patients compared with healthy pregnant women
(Açikgöz et al., 2013).
Studies performed in vivo, suggest placental steroid hormones
may be important in driving the changes in insulin sensitivity
and glucose metabolism of the mother during pregnancy
(Table 3). Hyperinsulinemic-euglycemic clamp studies in
women and rodents highlight a role for progesterone in reducing
maternal insulin sensitivity during pregnancy. Progesterone
administration decreases the ability of insulin to inhibit glucose
production by the liver, and diminishes insulin-stimulated
glucose uptake by skeletal muscle and to a lesser extent in the
adipose tissue of non-pregnant animals (Table 3; Progesterone;
Leturque et al., 1984; Ryan et al., 1985; Kim, 2009). In contrast,
exogenous estrogen increases whole body insulin sensitivity
in non-pregnant state (Table 3; Estrogen; Ahmed-Sorour
and Bailey, 1980). Similarly, genetic deficiency of ERα or
aromatase (Cyp19), which is involved in estrogen production,
reduces hepatic and whole body insulin sensitivity and impairs
glucose tolerance in non-pregnant mice (Takeda et al., 2003;
Bryzgalova et al., 2006). Loss of the estrogen receptor or
estrogen production is also associated with increased body
weight, adiposity and hepatic lipogenesis (Table 3; Estrogen;
Takeda et al., 2003; Bryzgalova et al., 2006). Progesterone and
estrogen also exert opposite effects on food intake in vivo
(Table 3). In particular, estrogen depresses food intake in part
via induction of leptin production by adipose tissue, whereas
progesterone increases food intake by enhancing NPY and
reducing CART expression by the hypothalamus (Table 3;
Fungfuang et al., 2013; Stelmanska and Sucajtys-Szulc, 2014).
Estrogen and progesterone however seem to have similar effects
on the pancreas; they both appear to induce islet hypertrophy
and/or increase pancreatic insulin levels and glucose-stimulated
secretion in vivo (Table 3; Costrini and Kalkhoff, 1971; Bailey
and Ahmed-Sorour, 1980). Nevertheless, there is some evidence
that progesterone may inhibit the PRL-induced proliferation
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TABLE 3 | In vivo effects of steroid hormones in vivo.
Hormones Expression
level
In vivo effects References
Estrogen Low Non-pregnant Estrogen receptor knockout ER−/− (ERKO, BERKO or viral-mediated ER
suppression mouse):
↓ glucose tolerance; whole body and hepatic insulin sensitivity; insulin-stimulated glucose
uptake by skeletal muscle; blood adiponectin, testosterone; sexual behavior
↑ body weight; abnormalities in vascular smooth muscle cells (ion channel function);
systolic and diastolic blood pressure; arterial pressure; heart failure; hepatic lipid
biosynthesis; adipose tissue mass; blood glucose, insulin, leptin
Zhu et al., 2002;
Bryzgalova et al., 2006;
Ribas et al., 2011
Aromatase knockout CYP19–/– (mouse):
↓ glucose and insulin tolerance; glucose oxidation; lean body mass
↑ body weight; adipocyte volume; blood glucose and testosterone




Estrogen receptor knockout ER−/− (ERKO, BERKO or viral-mediated ER
suppression mouse):
↓ litter size; maternal nurturing behavior (time spent nursing pups)
↔maternal aggression toward a male intruder
Ribeiro et al., 2012
ER antagonist (guinea pig):
↓ NOS activity in the cerebellum
Weiner et al., 1994
High Non-pregnant Exogenous estrogen in T1DM, T2DM model (mouse):
↓ oxidative stress (β cells); apoptosis; amyloid polypeptide toxicity; lipotoxicity
Tiano and
Mauvais-Jarvis, 2012
Exogenous (ovariectomized rat or mouse):
↓ hepatic glucose production; blood glucose; TNF-α macrophage synthesis;
gluconeogenesis; food intake (via ↑ leptin)





Zhang et al., 1999;
Storment et al., 2000;




↓ intimal cell proliferation in response to vessel injury
Zhang et al., 1999
Progesterone Low Non-pregnant Progesterone receptor knockout PR−/− (mouse):
↓ reproductive tissue development; ovulation; mammary gland development; sexual
behavior
↑ uterine mass, inflammation




↓ oxytocin production; oxytocin receptor synthesis
↑ premature birth; blood estrogen; oxytocin receptor synthesis
Fang et al., 1997
Exogenous antagonist (mouse):
↑ preterm parturition; myometrial monocytes near parturition (Cx-43)
Edey et al., 2018
High Non-pregnant Exogenous (mice):
↑ mammary gland lateral branching and number of stem cells
Joshi et al., 2010
Exogenous (ovariectomized rat):
↓ insulin-dependent suppression of endogenous hepatic glucose production
↑ insulin resistance in the liver, skeletal muscles and adipose tissue; eNOS expression in
the abdominal aortas, food intake (via ↑NPY, ↓CART)
↔ insulin-mediated glucose uptake (peripheral tissues), body weight




↑ uterine glycogen catabolism, glucose release




↑ myometrial monocyte numbers
↔ myometrial neutrophil numbers
Edey et al., 2018
Exogenous (ovariectomized mice):
↓ intimal proliferation in response to vessel injury
↑ anti-anxiety behavior (↑ hippocampal and prefrontal cortex 3α,5α-THP)
Koonce and Frye, 2013
eNOS, Endothelial nitric oxide synthase; PlGF, Placental growth factor; T1DM, Type 1 diabetes mellitus; T2DM, Type 2 diabetes mellitus; THP, Tetrahydroprogesterone; TNF, Tumor
necrosis factor; VEGF, Vascular endothelial growth factor.
and insulin secretion of β cells in vitro (Table 4; Progesterone;
Sorenson et al., 1993). Furthermore, in rodent models of
type 1 and 2 diabetes mellitus, estrogen supplementation
protects pancreatic β-cells from oxidative stress, lipotoxicity and
apoptosis (Table 3; Estrogen; Tiano and Mauvais-Jarvis,
2012). Therefore, both estrogen and progesterone play
roles in regulating insulin and glucose homeostasis, lipid
handling and appetite regulation, which may be important
in promoting metabolic changes in the mother during
pregnancy.
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TABLE 4 | Effects of steroid hormones in vitro.
Hormones Expression
level
In vitro effects References
Estrogen Low ER antagonist (human cytotrophoblast):
↓ proliferation
Kumar et al., 2009
High Exogenous (rat islets):
↔ PRL-induced β cell proliferation or insulin secretion
Sorenson et al., 1993
Exogenous (human umbilical venous endothelial cells):
↓ folic acid induced anti-angiogenic action
↑ leptin expression; differentiation
Lee et al., 2017
Exogenous (human, mouse, rat vascular smooth muscle cells):
↓ proliferation (↑ cell cycle arrest at G1)
↑ eNOS activity
Haynes et al., 2000; Hisamoto et al.,
2001; Takahashi et al., 2003
Exogenous (pregnant ewe uterine artery endothelial cells):
↑ angiogenesis (↑cell proliferation)
Jobe et al., 2010
Exogenous (rat coronary arteries):
↓ vasodilation (gender and oestrous cycle dependent)
↑ nitric oxide production (NOS)
Binko and Majewski, 1998; Shaw
et al., 2001
Exogenous (human myometrial cells):
↑ myometrial gap junction communication
Di et al., 2001
Progesterone Low No known physiological effects
High Exogenous (rabbit, rat coronary arteries):
↑ coronary relaxation (calcium influx dependent)
Jiang et al., 1992
Exogenous (human umbilical vein endothelial cells):
↓ LPS-induced leukocyte adhesion
↑ nitric oxide synthesis
Simoncini et al., 2004
Exogenous (human umbilical venous endothelial cells):
↓ leptin-induced invasion; folic acid-induced anti-angiogenic action; LPS-induced cytokine
secretion (TNF-α, IL-1β, IL-6, IL-8, MIP-1α, IL-10)
Garcia-Ruíz et al., 2015; Jo et al.,
2015; Lee et al., 2017
Exogenous (rat islets): ↓ PRL-induced β cell proliferation and insulin secretion Sorenson et al., 1993
Exogenous (mouse mammary epithelial cell):
↑ proliferation; DNA synthesis; lobulo-alveoli development
Plaut et al., 1999; Obr et al., 2013
Exogenous (human T cells):
↓ CD4 and CD8T cell proliferation and production of IFN-γ, TNF-α, IL-10, IL-5, IL-17, CD4
↑ CD4 and CD8T cell production of IL-4
Lissauer et al., 2015
CD, Cluster of differentiation; eNOS, Endothelial nitric oxide synthase; IL, Interleukin; LPS, Lipopolysaccharide; TNF, Tumor necrosis factor
Work conducted both in vitro and in vivo indicate that
estrogen and progesterone may also facilitate some of the
cardiovascular changes that accompany pregnancy (Tables 3,
4). Estrogen attenuates the vasoconstrictor responses of blood
vessels, impairs vascular smooth muscle cell proliferation and
calcium influx, and increases vasodilatory nitric oxide synthase
activity in vitro (Table 4; Estrogen; Takahashi et al., 2003). It
also increases uterine artery angiogenesis and amplifies the
vasodilatory impact of vascular endothelial growth factor on
isolated rat uterine vessels (Storment et al., 2000; Jobe et al.,
2010). In non-pregnant mice, deficiency of the ERβ gene leads
to defects in vascular smooth muscle function, hypertension and
signs of heart failure (Table 4; Estrogen; Zhu et al., 2002; Fliegner
et al., 2010). Conversely, estrogen supplementation appears to
protect the heart and vasculature from pressure overload or vessel
injury (Zhang et al., 1999; Zhu et al., 2002; Fliegner et al., 2010).
Progesterone also exerts cardiovascular effects. It stimulates
nitric oxide synthesis by human umbilical vein endothelial cells
in vitro and by rat abdominal aorta and mesenteric arteries
in vivo (Tables 3, 4; Progesterone; Chataigneau et al., 2004;
Simoncini et al., 2004). It also decreases blood pressure, when
infused into ovariectomised ewes and protects against vascular
injury in non-pregnant mice (Pecins-Thompson and Keller-
Wood, 1997; Zhang et al., 1999). In culture, progesterone induces
hypertrophy and inhibits apoptosis of rodent cardiomyocytes
(Morrissy et al., 2010; Chung et al., 2012). Thus, via its impacts
on cardiomyocytes, progesterone may mediate the pregnancy-
induced growth of the mother’s heart in vivo. In late pregnancy,
the murine heart shifts to use fatty acids, rather than glucose
and lactate, as a metabolic fuel. In part, this metabolic shift
is proposed to be mediated by progesterone during pregnancy,
which inhibits pyruvate dehydrogenase activity in ventricular
myocytes (Liu et al., 2017). Thus, placental-derived progesterone
and estrogen may mediate part of the changes in the maternal
cardiovascular system during pregnancy.
In many mammalian species, progesterone levels decline just
before parturition and this is associated with the initiation of
labor. Indeed, in rodents, inhibition of progesterone synthesis or
administration of a progesterone antagonist results in premature
delivery of the neonate (Table 3; Progesterone; Fang et al., 1997;
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Kota et al., 2013). In humans, circulating progesterone levels
continue to be high until birth. Commencement of labor is
therefore proposed to be related to a functional withdrawal of
progesterone activity in the myometrium of women (Brown A.
G. et al., 2004; Norwitz and Caughey, 2011). In experimental
animals, progesterone reduces the production of prostaglandins
and decreases the expression of contraction-associated genes
including oxytocin and prostaglandin receptors, gap junction
proteins and ion channels in the myometrium (Table 3;
Progesterone; Fang et al., 1997; Soloff et al., 2011; Edey et al.,
2018). Together, these progesterone-mediated actions decrease
contractility of uterine smooth muscle cells and maintain uterine
quiescence until term. In contrast to progesterone, estrogen levels
rise prior to term and estrogen promotes the expression of
contraction-associated genes and contraction of themyometrium
(Table 4; Estrogen; Nathanielsz et al., 1998; Di et al., 2001;
Chandran et al., 2014). Therefore, in many species, the high
ratio of estrogen to progesterone in the maternal circulation
is thought to contribute the onset of labor. Parturition is
associated with an influx of inflammatory cells and release of
pro-inflammatory cytokines, including interleukin (IL)-1β and
tumor necrosis factor (TNF)-α, in the myometrium, cervix and
fetal membranes (Golightly et al., 2011). In mice, progesterone
reduces the expression of pro-inflammatory cytokines, including
IL-1β and IL-6 by the uterus and trophoblast and may modulate
the abundance of myometrial monocytes (Table 3; Estrogen;
Edey et al., 2018). Progesterone also decreases the ability of
LPS to induce pro-inflammatory cytokine secretion by human
myometrium and placental explants (Youssef et al., 2009; Garcia-
Ruíz et al., 2015). It also diminishes the ability of estrogen
to induce the infiltration of macrophages and neutrophils into
the uterus, and decreases LPS-induced leukocyte adhesion to
human umbilical vein cells (Simoncini et al., 2004). Thus,
it is perhaps not surprising that progesterone receptor null
mice demonstrate chronic uterine inflammation, particularly
in response to estrogen treatment (Table 3; Estrogen; Lydon
et al., 1995). There is also evidence that placental steroids
participate in cervical softening, by regulating the expression
of matrix remodeling enzymes as well as leukocyte infiltration
and function (Chinnathambi et al., 2014; Gopalakrishnan et al.,
2016; Berkane et al., 2017). In addition to regulating the events
leading to parturition, recent data suggest that during the course
of pregnancy, both estrogen and progesterone contribute to the
maternal tolerance of the fetus by modulating proliferation and
cytokine expression of CD4 and CD8T cells and enhancing
the suppressive function of T-regulatory cells (Mao et al., 2010;
Robinson and Klein, 2012; Lissauer et al., 2015).
Additionally, both estrogen and progesterone are key
stimulators of mammary gland development. For instance,
progesterone stimulates proliferation of mammary stem cells
and mammary epithelium (Tables 3, 4; Progesterone; Joshi
et al., 2010; Lee et al., 2013). In mice, deficiency of the
progesterone receptor restricts mammary gland development,
whereas exogenous progesterone induces ductal side branching
and lobuloalveolar differentiation and development (Table 3;
Progesterone; Plaut et al., 1999; Joshi et al., 2010). In addition,
both estrogen and progesterone may have indirect effects on
mammary gland development by regulating prolactin secretion
from the pituitary gland (Rezaei et al., 2016).
Maternal behavior during and after birth are regulated by
the steroid hormones. Estrogen stimulates maternal nurturing
behavior in numerous species, including rats, mice, sheep and
primates (Bridges, 2015). In particular, maternal care is induced
by estrogen treatment, whereas the converse happens when ERα
expression is suppressed; deficiency of ERα increases the latency
to pup retrieval and reduces the length of time dams spend
nursing and licking their pups (Table 3; Estrogen; Ribeiro et al.,
2012). Findings from animal models suggest that progesterone
plays a role in regulating anxiety and depression-related behavior.
For instance, exogenous progesterone stimulates anti-anxiety and
anti-depressive actions in mouse dams (Table 3; Progesterone;
Koonce and Frye, 2013). In contrast, progesterone withdrawal
increases these types of behaviors (Gulinello et al., 2002).
Thus, placental-derived steroids may modulate several aspects of
maternal physiology which are beneficial to both pregnancy and
post-partum support of the offspring.
Neuroactive Hormones
One major target of placental hormones is the maternal brain
and related neuroendocrine organs such as the hypothalamus and
pituitary glands. These neuroendocrine effects enable the mother
to respond and adapt accordingly to her environment, so as to
mitigate the adverse effects of stress and maintain homeostasis
(Voltolini and Petraglia, 2014). Neuroactive hormones also
prepare and enable the future mother to adequately care
for her young (Lévy, 2016). In addition to their impact on
the maternal neuroendocrine system, these hormones have
additional functions in vivo and in vitro functions as well, which
are detailed in Tables 5, 6, respectively.
Melatonin and Serotonin
Melatonin and its precursor, serotonin, are tryptophan-derived
hormones with well-known neuroendocrine impacts. In humans,
circulating concentrations of melatonin and serotonin increase
as pregnancy advances (Lin et al., 1996; Nakamura et al.,
2001). In the non-pregnant state, melatonin and serotonin
are primarily produced by the pineal gland and the brain,
respectively. However, the enzymes involved in melatonin
and serotonin biosynthesis are also expressed by the human
placenta throughout gestation (Iwasaki et al., 2005; Soliman
et al., 2015; Laurent et al., 2017). The mouse placenta similarly
expresses the enzymes needed for serotonin synthesis (Wu
et al., 2016), although work is required to assess if melatonin
synthesizing enzymes are also expressed. The rat placenta does
not produce melatonin de novo due to the lack of synthesizing
enzymes (Tamura et al., 2008). However, the same study
demonstrated that conditioned medium from cultured term
rat placentas stimulated melatonin release by the maternal
pineal gland (Tamura et al., 2008). These findings suggest
that placental-derived factors may indirectly regulate melatonin
levels by the mother during pregnancy. Placental expression
of melatonin, serotonin and their respective enzymes, also
remains to be investigated in other species such as rabbits
and sheep, which are commonly used in pregnancy-related
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TABLE 5 | Effects of neuropeptides in vivo.
Hormones Expression
level
In vivo effects References
Serotonin Low Non-
pregnant
Serotonin receptor knockout Htr3a −/− (mouse):
↔ glucose tolerance; GSIS; serotonin production and release; pancreatic β-cell mass
Ohara-Imaizumi et al.,
2013
Dietary restriction of precursor – tryptophan/inhibitor of serotonin synthase or
receptor/serotonin receptor knockout Htr2b−/− (mouse):
↔ glucose tolerance
Kim et al., 2010
Serotonin transporter knockout SERT −/−(mouse):
↓ food intake; glucose and insulin tolerance; hepatic and white adipose tissue glucose
uptake and insulin sensitivity (Akt signaling); estrus cyclicity; blood 17β-estradiol; brown
adipose tissue mass; lipid droplet number; lipolysis (PGC1α, PPARα, and CPT1b); ovarian
Cyp19a expression
↑ blood glucose; white adipose tissue mass; adipocyte size; lipid droplet area; lipogenesis
(PPARγ, SREBP1c, Fabp4, LPL, HSL and ATGL); adipose inflammation (IL-6 and TNF-α)
Zha et al., 2017
Administration of selective serotonin-reuptake inhibitors (mouse):
↓ glucose and insulin tolerance; blood 17β-estradiol; ovarian Cyp19a expression
↑ weight; adiposity; adipocyte size
Alenina et al., 2009; Kane
et al., 2012
Serotonin synthesis pathway enzyme knockout Tph2−/− (mouse):
↓ postnatal survival; heart rate; blood pressure; respiration; social interaction; blood IGF1




Serotonin receptor knockout Htr3a −/− (mouse):
↓ glucose tolerance; GSIS
↔ weight; pancreatic β cell mass expansion; serotonin production and release; litter size
Ohara-Imaizumi et al.,
2013
Serotonin synthesis pathway enzyme Tph1−/− (mouse):
↓ blood and mammary serotonin and PTHrP; blood calcium; osteoclast activity; mammary
gland epithelial cell proliferation, calcium transporters and sonic hedgehog signaling
↑ blood glucose and insulin
Laporta et al., 2014a,b
Serotonin synthesis pathway enzyme Tph2−/− (mouse):
↓ brain serotonin; pup retrieval; nest building; offspring survival and weaning weights;
lactation; lactation-induced aggression
↑ pup killing
Angoa-Pérez et al., 2014
Dietary restriction of precursor – tryptophan /inhibitor of serotonin synthase or
receptor/serotonin receptor knockout Htr2b−/− (mouse):
↓ glucose tolerance; pancreatic β-cell expansion (proliferation); blood insulin
↔ insulin tolerance
Kim et al., 2010
Serotonin transporter SERT −/−(mouse):
↑ blood glucose and insulin; JZ necrosis (TUNEL positive cells) and hemorrhage (fibrin
deposition)
Hadden et al., 2017
High Non-
pregnant




Infusion of serotonin precursor (cow):
↓ food intake; colostrum yield; urine calcium elimination
↑ blood FFAs, calcium content; colostrum serotonin; loose stools; defecation frequency;
urine metabolite (deoxypyridinoline); milk calcium content; hepatic expression of serotonin;
hepatic CASP3- and Ki67-positive cell numbers
↔ blood glucose, insulin, magnesium, prolactin, glucagon; weight; milk yields; heart rates;
respiration rates; body temperatures
Laporta et al., 2015;




Injection of precursor – tryptophan (mouse, rat and rabbit):
↓ uterine blood flow; decidualization
↑ termination of pregnancy; placental hemorrhage; circulating PRL
↔ uterine contractility; serum progesterone
Poulson et al., 1960;
Robson and Sullivan,
1966; Habiger, 1975
Mitchell et al., 1983;
Tomogane et al., 1992
Dietary intake of precursor – tryptophan (mice, rats):
↓ blood insulin; milk glucose
↑ blood, liver and mammary gland serotonin; blood and mammary gland PTHrP; blood
and milk calcium; liver expression of gluconeogenic and glycolytic enzymes (PC, PCK,
PDK4, PFK1); mammary gland expression of TPH1, calcium transporters, glucose
transporters; femur bone resorption
↔ body weight; mammary gland structure and milk yield; pup weights
Laporta et al., 2013a,b
(Continued)
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TABLE 5 | Continued
Hormones Expression
level
In vivo effects References
Melatonin Low Non-
pregnant
Melatonin receptor knockout MT1−/− (mouse):
↓ glucose and insulin tolerance; circadian rhythm of blood glucose and corticosterone;
time spent resting
↑ depressive-like and anxiety-like behaviors; psychomotor disturbances; time spent
eating; hyperactivity; blood corticosterone and glucose; pancreatic insulin production; liver
glucagon receptor expression




2014; Comai et al., 2015;
Owino et al., 2016
Melatonin receptor knockout MT2−/− (mouse):
↓ circadian rhythm of blood glucose; blood insulin; axon formation; synaptic transmission
↑ liver glucagon receptor expression; pancreatic insulin production
Liu et al., 2015
Double melatonin receptor knockout MT1/MT2−/− (mouse):
↓ blood insulin
↑ cognitive performance; hyperactivity; motor activity; liver glucagon receptor expression;
pancreatic insulin production
Mühlbauer et al., 2009;
Bähr et al., 2011;








↓ liver glucagon receptor expression
↑ blood glucagon
Bähr et al., 2011
Mammary-specific melatonin MT1 receptor overexpression (mouse):
↓ mammary gland ductal growth, ductal branching, and terminal end bud formation





↑ heart rate; pulse pressure; uterine blood flow; uterine melatonin receptor expression
↓ circulating progesterone and estradiol
↔ gestation and birthweight
Brockus et al., 2016
Exogenous (sheep):
↓ pancreatic insulin-positive tissue area, size and percentage of large insulin-containing
cell clusters; blood prolactin receptors; milk protein content (β-casein and whey acidic
protein)
↑ oxygen consumption; blood LH and progesterone; pancreas and small intestine
weights; pancreatic α-amylase activity; citrate synthase activity; number of fetuses;
conception and pregnancy rates
Wallace et al., 1988;
Denicolo et al., 2008;
Scott et al., 2009;
Prezotto et al., 2014;
Keomanivong et al., 2016
Exogenous in growth restriction model – high altitude (sheep):
↓ oxidative stress (↓ blood 8-isoprostanes); birthweight




↓ food intake; weight gain; blood and pituitary LH; pituitary prolactin; litter size; birthweight
↑ blood prolactin; offspring mortality
Nir and Hirschmann,
1980; Jahnke et al.,
1999; Singh et al., 2013
Melatonin receptor MT1 overexpression (mouse):
↓ mammary gland lobulo-alveolar development; mammary epithelial cell proliferation
(Akt1, phospho-Stat5, Wnt4) and estrogen and progesterone receptor expression;
suckling pup weight




↓ glucose and insulin tolerance; bone mineral density; social memory; maternal behavior
(pup retrieval and licking)
↑ adiposity; sucrose solution intake; carbohydrate preference; blood glucose, leptin and
adrenaline
↔ food intake
Ferguson et al., 2000;
Amico et al., 2005;
Pedersen et al., 2006;
Miedlar et al., 2007;
Sclafani et al., 2007;
Camerino, 2009; Tamma
et al., 2009
Oxytocin receptor knockout OTR −/−(mouse):
↓ bone mineral density; cold-induced thermogenesis; social memory; maternal behavior
(pup retrieval)
↑ adiposity; aggressive behavior; blood triglycerides; brown adipose tissue lipid droplet
size
Takayanagi et al., 2005,
2008; Lee et al., 2008;
Tamma et al., 2009
Oxytocin antagonist administration (rat):
↓ latency to first meal post-fast
↑ food and fluid intake; time spent eating
Arletti et al., 1989, 1990
OXTR RNAi administration (prairie voles):
↓ social attachment; maternal care (grooming)
Keebaugh et al., 2015
(Continued)
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TABLE 5 | Continued
Hormones Expression
level




Oxytocin knockout OT −/−(mouse):
↓ milk release; post-partum mammary development
↑ mammary gland milk accumulation
Nishimori et al., 1996;
Young et al., 1996;
Wagner et al., 1997
Oxytocin receptor knockout OTR −/−(mouse):
↓ milk release; maternal behavior (pup retrieval)
↑mammary gland milk accumulation
Takayanagi et al., 2005;
Lee et al., 2008
Oxytocin antagonist administration (rat):
↑ latency to display maternal behaviors (nest building, pup retrieval)





↓ food and fluid intake; blood pressure; blood calcium
↑ latency to first meal post-fast; bone formation
Arletti et al., 1989, 1990;
Petersson et al., 1996;
Elabd et al., 2007
Exogenous (diet-induced obese rats):
↓ weight gain
↑ glucose and insulin tolerance; adipose tissue lipolysis and fatty acid β-oxidation
Deblon et al., 2011
Exogenous (mouse):
↑ body temperature; bone mineral density
Mason et al., 1986;





↑ delivery induction (via induced Fos expression in supraoptic nucleus and brain stem
neurons)
Antonijevic et al., 1995
Injection of oxytocin antagonist (Syrian hamster):
↑ aggression to intruder (number of bites and contact time)
Ferris et al., 1992
ATGL, Adipose triglyceride lipase; CASP, Caspase; CPT1b, Carnitine palmitoyltransferase 1B; GSIS, Glucose-stimulated insulin secretion; HSL, Hormone-sensitive lipase; IL, Interleukin;
JZ, junctional zone; PC, Pyruvate carboxylase; PDK4, Pyruvate dehydrogenase kinase 4; PFK1, 6-phosphofructokinase subunit alpha; PGC1, PPARG Coactivator 1; PPAR, Peroxisome
proliferator-activated receptor; SREBP1, Sterol regulatory element-binding transcription factor 1; LPL, Lipoprotein lipase; TNF, Tumor necrosis factor.
studies. Mouse models that result in deficiencies or reduced
bioactivity of these hormones demonstrate altered sleep patterns,
melancholic behavior, hyperactivity and aggression in the
non-pregnant state (Table 5; Serotonin and Melatonin; Weil
et al., 2006; Alenina et al., 2009; Kane et al., 2012; Adamah-
Biassi et al., 2014; O’neal-Moffitt et al., 2014; Comai et al.,
2015). Serotonin is thus a major regulator of maternal mood
and behavior (Angoa-Pérez and Kuhn, 2015). For instance,
genetically-induced serotonin deficiency leads to increased
maternal aggression, lower pup retrieval and greater pup
cannibalization, which reduces postnatal survival of offspring
in mice (Angoa-Pérez et al., 2014). There is some evidence
that serotonin and melatonin may also impact maternal feeding
behavior. For example, increased serotonin signaling reduces
food intake in pregnant cows (Laporta et al., 2015; Weaver
et al., 2016, 2017; Hernández-Castellano et al., 2017). Similarly,
exogenous melatonin lowers food intake in pregnant rats (Nir
and Hirschmann, 1980; Jahnke et al., 1999; Singh et al., 2013).
These negative effects on maternal food intake suggest that peak
serotonin and melatonin concentrations in late pregnancy may
serve to control the maternal appetite and prevent excessive
weight gain.
Another key function of melatonin and serotonin is glucose
homeostasis and the regulation of steroid synthesis (Table 5;
Serotonin and Melatonin). In mice, loss of melatonin or
serotonin signaling leads to glucose intolerance and insulin
resistance, with consequences for blood glucose and insulin
concentrations in both the non-pregnant and pregnant
state (Contreras-Alcantara et al., 2010; Kim et al., 2010;
Owino et al., 2016). However, these neuroactive hormones
appear to have differential effects on the pancreas (Table 6;
Serotonin and Melatonin). Serotonin promotes pancreatic
β-cell proliferation in vitro (Kim et al., 2010), and is thus
important for pancreatic β-cell mass expansion during
pregnancy in mice (Goyvaerts et al., 2016). In contrast,
melatonin reduces insulin release by rodent pancreatic islets
in vitro (Mühlbauer et al., 2012). Non-pregnant mice with
deficient serotonin signaling have impaired lipid handling
and excessive lipid accumulation in association with reduced
adipose aromatase expression and circulating estrogen (Zha
et al., 2017). Similarly, treating placental-derived trophoblast
cells with norfluoxetine, a selective serotonin-reuptake inhibitor,
inhibits aromatase activity and estrogen secretion in vitro
(Hudon Thibeault et al., 2017). Supplementation of melatonin
in non-pregnant humans reduces circulating triglycerides and
cholesterol levels, but effects of lipid handling in pregnancy
are unknown (Mohammadi-Sartang et al., 2017). Melatonin
also modulates steroid production. For instance, melatonin
treatment in pregnant cows reduces circulating estrogen and
progesterone (Brockus et al., 2016), while lack of melatonin
signaling raises blood corticosterone in mice (Comai et al.,
2015).
Given melatonin’s additional effects on regulating the
circadian rhythm (Mühlbauer et al., 2009), there is some weak
evidence for its role in the timing of parturition (Yellon and
Longo, 1988; González-Candia et al., 2016). Melatonin can either
enhance or reduce uterinemyometrial contractility depending on
the species (Table 6; Melatonin; Ayar et al., 2001; Sharkey et al.,
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TABLE 6 | Effects of neuropeptides in vitro.
Hormones Expression
level
In vitro effects References
Serotonin Low Exposure to selective serotonin-reuptake inhibitors (BeWo trophoblast cell and
H295R adrenocortical cell co-culture):
↓ serotonin transporter activity; estrogen secretion
↑ aromatase CYP19 activity
Hudon Thibeault et al., 2017
High Exogenous (human third trimester placental arteries and veins):
↑ vessel vasoconstriction; cotyledon; perfusion pressure and thromboxane release
Bjøro and Stray-Pedersen, 1986;
Cruz et al., 1997
Exogenous (bovine placentome cells):
↑ proliferation
Fecteau and Eiler, 2001
Exogenous (human adipocytes):
↑ lipid-binding proteins, glucose carriers, triacylglycerol synthesis enzymes
Sonier et al., 2005
Exogenous (mouse adipocytes):
↓ brown fat differentiation
↑ fat storage and white fat differentiation; lipid-binding proteins, glucose carriers, triacylglycerol
synthesis enzymes
Grès et al., 2013; Rozenblit-Susan
et al., 2017
Exogenous (mouse pancreatic β cells):
↑ proliferation
Kim et al., 2010
Exogenous (rat osteoblast):
↓ proliferation; differentiation; mineralization
Dai et al., 2014
Melatonin Low Melatonin receptor MT1 siRNA administration (rat insulinoma):
↑ insulin production and secretion
Wang et al., 2017
High Exogenous (human trophoblast cells):
↑ hCG secretion; syncytialization
↓ hypoxia-induced oxidative stress and apoptosis; mitochondrial lipid peroxidation
Iwasaki et al., 2005; Milczarek et al.,
2010; Lanoix et al., 2013; Soliman
et al., 2015
Exogenous (human myometrial cells):
↑ oxytocin-induced contractility; oxytocin sensitization
Ayar et al., 2001; Sharkey et al.,
2009, 2010
Exogenous (rat myometrial cells):
↓ spontaneous and oxytocin-induced contractility
Abd-Allah et al., 2003
Exogenous (rat uterine and hypothalamic explants):
↓ prostaglandin release
Gimeno et al., 1980
Exogenous (seal uterine artery):
↓ noradrenaline-induced vasoconstriction
Stokkan and Aarseth, 2004
Exogenous (rat insulinoma and mouse pancreatic islets):
↓ insulin release; expression of glucagon-like peptide 1; glucagon-stimulated insulin release
Mühlbauer et al., 2012
Exogenous (mouse pancreatic α-cells):
↑ glucagon production
Bähr et al., 2011
Oxytocin Low Oxytocin knockout OT−/−(mouse osteoblast and osteoclast cells):
↓ proliferation; maturation; differentiation
Tamma et al., 2009
High Exogenous (human third trimester primary trophoblast cells):
↓ nitric oxide production
Nanetti et al., 2015
Exogenous (human decidual cells in labor):
↑ prostaglandin synthesis; release of free arachidonic acid
Wilson et al., 1988
Exogenous (guinea pig placenta perfusion):
↓ uptake of glucose and alanine (related to changes in placental flow)
Rybakowski et al., 2000
Exogenous (rat myometrial strips):
↑ contractility
Ayar et al., 2001
Exogenous (rat mammary gland slice):
↑ release of triglycerides and protein
Da Costa et al., 1995
Exogenous (human umbilical vein endothelial cells):
↑ migration; invasion
Cattaneo et al., 2008
Exogenous (mouse osteoblast and osteoclast):
↑ proliferation; differentiation
Tamma et al., 2009
2009, 2010). Both melatonin and serotonin are also important for
lactation, specifically for mammary gland development and milk
nutrient content (Okatani et al., 2001; Xiang et al., 2012; Laporta
et al., 2014a,b). For instance, mammary gland proliferation
and calcium transport is impaired in pregnant mice with
genetically-induced serotonin deficiency (Laporta et al., 2014a,b).
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Conversely, supplementation of a serotonin precursor increases
mammary calcium transporter expression and milk calcium
content in lactating mice and cows (Laporta et al., 2013a,b, 2015;
Weaver et al., 2016, 2017; Hernández-Castellano et al., 2017). In
contrast to serotonin, increased melatonin signaling is associated
with reduced ductal growth and branching, as well as impaired
terminal end bud formation in the non-pregnant state (Xiang
et al., 2012). Thus, during lactation, these mice with increased
melatonin signaling have impaired mammary gland lobulo-
alveolar development and reduced milk protein content, which
reduces the weight of suckling pups (Xiang et al., 2012). Indeed,
a recent study showed antenatal melatonin supplementation
further exacerbated the growth restriction of offspring and
raised circulating maternal cortisol in a sheep model of fetal
growth restriction (González-Candia et al., 2016). Nevertheless,
melatonin supplementation during pregnancy confers significant
beneficial neuroprotective effects on the fetus and enhances
maternal antioxidant capacity (Miller et al., 2014; González-
Candia et al., 2016; Castillo-Melendez et al., 2017). Therefore,
while melatonin supplementation shows promise for use in
the clinic, particularly for enhancing the neurodevelopmental
outcomes of offspring in growth compromised pregnancies,
the potential adverse outcomes for both mother and child
must also be considered and should be assessed in further
studies.
Oxytocin
Another key neuroendocrine factor is oxytocin. Oxytocin is
widely known for its role in triggering maternal nursing behavior
(Bosch and Neumann, 2012). This is mediated by oxytocin’s
actions on the maternal brain, as well as, the mammary glands.
Indeed, a greater rise in circulating oxytocin concentrations
from early to late pregnancy in pregnant women, is associated
with a stronger bond between a mother and her infant (Levine
et al., 2007). Concurrently, placental expression of oxytocin also
peaks at term in humans (Kim S. C. et al., 2017). The rat
placenta also produces oxytocin (Lefebvre et al., 1992), while
placental expression in other species remains unclear. Reduced
oxytocin signaling decreases maternal nurturing behavior such
as pup retrieval in rats (Van Leengoed et al., 1987). It also
decreases the willingness of female voles to care for, groom
and lick unrelated pups (Keebaugh et al., 2015). Low oxytocin
signaling can additionally impair social bonding in voles and
mice (Ferguson et al., 2000; Takayanagi et al., 2005; Lee et al.,
2008; Keebaugh et al., 2015), while high levels builds trust and
cooperation in a group setting to facilitate group survival in
humans (Declerck et al., 2010; De Dreu et al., 2010). Moreover,
a lack of oxytocin disrupts mammary gland proliferation and
lobuloalveolar development, which impairs milk release from
the mammary tissues in mice (Nishimori et al., 1996; Wagner
et al., 1997). Therefore, high oxytocin levels enable the mother
to bond better and protect her newborn, when it is most
vulnerable.
Oxytocin is also important in the process of parturition
(Table 6; Oxytocin); it stimulates the contraction of smooth
muscle cells in the myometrium (Ayar et al., 2001; Arrowsmith
and Wray, 2014), by inducing calcium influx and stimulating
prostaglandin release (Wilson et al., 1988; Voltolini and Petraglia,
2014; Kim S. H. et al., 2017). Cardiovascular effects of oxytocin
include its ability to significantly lower blood pressure in non-
pregnant rats (Petersson et al., 1996). There is also some evidence
that oxytocin induces anti-inflammatory and antioxidant effects
in the heart under hypoxic conditions in non-pregnant rats
(Gutkowska and Jankowski, 2012). Nevertheless, the specific
cardiovascular effects of oxytocin in pregnancy remain to be
explored.
Studies performed in non-pregnant rodents show that
oxytocin also affects metabolic function in vivo (Table 5;
Oxytocin). In particular, loss of oxytocin reduces glucose and
insulin tolerance and increases adiposity (Camerino, 2009),
whereas exogenous oxytocin has the reverse effect (Deblon et al.,
2011). Studies are however, required to determine whether the
rise in oxytocin in late pregnancy (Levine et al., 2007) may
serve to improve insulin sensitivity in the mother in preparation
for the metabolic requirements of delivery and lactation. There
is some evidence that oxytocin may additionally play a role
in controlling energy expenditure and thermoregulation during
pregnancy. Even with a similar diet and activity level to control
mice, oxytocin-deficient mice become obese due to reduced
energy expenditure from poor thermoregulation in the non-
pregnant state (Chaves et al., 2013). Furthermore, exogenous
oxytocin in non-pregnant mice causes a rise in body temperature
(Mason et al., 1986; Tamma et al., 2009). Nevertheless, whether
oxytocin may play a role in controlling heat dissipation due
to the increased maternal energy expenditure during pregnancy
requires exploration. Exogenous oxytocin also reduces food
intake in non-pregnant rats (Arletti et al., 1989, 1990). However,
the role of oxytocin in appetite regulation during pregnancy
remains to be explored. There is also evidence for oxytocin’s
possible involvement in maternal bone metabolism and calcium
homeostasis during pregnancy and lactation. For instance,
oxytocin stimulates both bone resorption and bone formation
by osteoclasts and osteoblasts respectively in vitro (Tamma
et al., 2009). Moreover, oxytocin administration in rats reduces
circulating calcium with an overall skew toward bone formation
(Elabd et al., 2007). These findings may suggest that the peak
in circulating oxytocin toward term promote the restoration of
depleted maternal skeletal calcium stores.
Other Neuroactive Hormones
In addition to the aforementioned melatonin, serotonin and
oxytocin, the human placenta also produces neuroactive
hormones such as kisspeptin and thyrotropin-releasing hormone
(TRH), which may function in adapting maternal physiology
to support pregnancy (Bajoria and Babawale, 1998; De Pedro
et al., 2015). In humans, circulating kisspeptin rises throughout
pregnancy to concentrations 10,000-fold that of the non-
pregnant state, with the placenta speculated as a major source
(Horikoshi et al., 2003). In the non-pregnant state, kisspeptin can
both stimulate and impede glucose stimulated insulin secretion
in mice (Bowe et al., 2009; Song et al., 2014). The nature of the
effect may partly relate to differences in the actions of kisspeptin
isoforms on pancreatic islets (Bowe et al., 2012). Kisspeptin
may also have effects on the maternal cardiovascular system,
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given its reported vasoconstrictive effects on vascular smooth
muscle cells and fibrotic effects on the heart in non-pregnant
rats (Mead et al., 2007; Zhang et al., 2017). Studies in humans
highlight the importance of regulating kisspeptin production
during gestation; increased placental kisspeptin is associated
with pre-eclampsia (Whitehead et al., 2013; Matjila et al., 2016)
and reduced circulating kisspeptin is observed in women with
hypertension and diabetes during pregnancy (Cetkovic´ et al.,
2012; Matjila et al., 2016). Like the human, the murine placenta
produces kisspeptin. Although a kisspeptin-deficient mouse has
been established, previous work has been focused on feto-
placental outcomes, with no examination of maternal physiology
(Herreboudt et al., 2015). Studies are required to determine the
consequences of abnormal placental kisspeptin on the maternal
physiology during pregnancy.
In the non-pregnant state, hypothalamic TRH stimulates
release of thyroid-stimulating hormone and PRL from the
pituitary (Hershman et al., 1973; Vale et al., 1973; Askew and
Ramsden, 1984). However, during pregnancy, the placenta serves
as an additional source of TRH (Bajoria and Babawale, 1998).
Excess TRH in pregnancy raises blood concentrations of thyroid-
stimulating hormone and PRL in humans, rhesusmonkeys, sheep
and rats (Thomas et al., 1975; Azukizawa et al., 1976; Roti
et al., 1981; Moya et al., 1986; Lu et al., 1998). Conversely, a
lack of TRH reduces blood PRL in mice (Rabeler et al., 2004;
Yamada et al., 2006). Thyroid hormones are necessary for optimal
brain development as well as thyroid function (Miranda and
Sousa, 2018). Impaired TRH signaling is associated with anxiety-
like and depressive-like behavior in non-pregnant mice (Zeng
et al., 2007; Sun et al., 2009) and there is some evidence which
suggests a link between thyroid dysfunction and poor maternal
mood during pregnancy in humans (Basraon and Costantine,
2011). However, whether any direct causal relationship between
placental hormones, like TRH and perinatal depression remains
unclear. Additionally, TRH is implicated in glucose homeostasis
and appetite regulation. For example, mice with TRH deficiency
are hyperglycaemic, due to an impaired insulin response to
glucose (Yamada et al., 1997). Reduced TRH signaling also
impedes leptin production and ghrelin acylation, which results
in less energy conservation during fasting and a lower body
mass in the non-pregnant state (Groba et al., 2013; Mayerl et al.,
2015). Investigations are warranted to identify whether TRHmay
contribute to the regulation of glucose handling and appetite in
the mother during pregnancy.
Additional Hormones
The placenta also produces numerous other hormones with
pleiotropic effects. Several key ones, which have been implicated
in pregnancy failure or disorders of pregnancy such as
hypertension, hyperglycemia and hypercalcemia, are discussed
here. The hormones presented here are by no means exhaustive
and were selected primarily on their major associations
with abnormal maternal physiology during pregnancy. The
gonadotropin, chorionic gonadotropin (CG); transforming
growth factor β (TGF β) family member, activin; angiogenic
factor, relaxin; bone metabolism-associated parathyroid
hormone-related protein (PTHrP) and energy homeostasis
regulator, leptin are reviewed (Tables 7, 8).
Chorionic Gonadotropin (CG)
CG, is secreted by the human (hCG) and equine (eCG) placenta,
although hCG has been more extensively studied. hCG is a
large glycoprotein composed of α and β subunits, of which
the α subunit identical to luteinizing hormone (LH), follicle
stimulating hormone (FSH) and thyroid stimulating hormone
(TSH). As a result, hCG can interact with LH, FSH and TSH
receptors. In women, hCG is secreted from the trophoblast
from very early in gestation and is thought to be the first
placental hormone to act on the mother (Ogueh et al., 2011).
Indeed, maternal circulating hCG concentrations peak in the first
trimester and then decline toward term (Ogueh et al., 2011).
In early pregnancy, hCG maintains corpus luteum allowing
the continued secretion of ovarian progesterone and estrogens
until the steroidogenic activity of the fetal-placental unit can
compensate for maternal ovarian function (Fournier et al.,
2015). In particular, hCG increases the abundance of low-
density lipoprotein receptor and thus uptake of cholesterol
for steroidogenesis. It also enhances the expression and/or
activity of steroidogenic enzymes including 3β-hydroxysteroid
and aromatase. There is also some evidence which suggests
hCG may inhibit factors that promote luteal demise, such as
the prostaglandins. The high levels of hCG in early pregnancy
are also sufficient to bind to the TSH receptor and may act
to increase maternal thyroid hormone production, which as
mentioned previously, may exert effects in the mother and fetus.
CG may also play important autocrine and paracrine roles
at the maternal-fetal interface. Administration of hCG antisera
prevents implantation in marmoset in vivo (Hearn et al., 1988).
Recent proteomic analysis of estrogen and hCG treated human
endometrial epithelial cells demonstrates that hCG targets
pathways involved in metabolism, basement membrane and cell
connectivity, proliferation and differentiation, cellular adhesion,
extracellular-matrix organization, developmental growth, growth
factor regulation and cell signaling (Greening et al., 2016). Such
pathways are likely to be important for placental development,
as attenuating hCG signaling disrupts trophoblast differentiation
in vitro (Shi et al., 1993). In contrast, supplementing human
trophoblast cells with hCG increases their differentiation,
migration, invasion and adhesion to uterine epithelial cells, and
decreases their leptin secretion in vitro (Table 8; hCG; Shi et al.,
1993; Prast et al., 2008; Lee C. L. et al., 2013; Chen et al., 2015).
hCG also promotes angiogenic vascular endothelial growth
factor secretion by both trophoblast and endometrial epithelial
cells (Islami et al., 2003a; Berndt et al., 2006) and enhances
endothelial tube formation and migration (Zygmunt et al., 2002).
Furthermore, hCG is key in suppressing the maternal immune
system from mounting a response against paternal antigens
carried by the allogenic conceptus. Administration of hCG in a
mouse model of spontaneous abortion significantly reduces the
number of fetal resorptions due to improved immune tolerance
of the fetus (Schumacher et al., 2013). In vitro, hCG enhances
proliferation of immunosuppressive uterine natural killer cells
(Kane et al., 2009), and the production of immunosuppressing
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TABLE 7 | Effects of additional hormones in vivo.
Hormones Expression
levels
In vivo effects References
Activins Low Non-
pregnant
Dysfunctional activin receptor ACVR1C (mouse):
↓ fat accumulation
↑ adipocyte lipolysis
Yogosawa et al., 2013
Truncated activin receptor ACVR2A (mouse):
↑ number and area of renal glomeruli
↓ size of renal glomeruli
Maeshima et al., 2000
Bone-specific activin receptors ACVR2A and/or ACVR2B deletion (mouse):
↑ femoral trabecular bone volume




No known physiological effects
High Non-
pregnant
Induced endogenous overexpression (mouse):
↑ estrus stage in cycle; blood activin A and FSH; numbers of corpora lutea; granulosa cell
layer thickness; ovary size
Kim et al., 2008
Exogenous (mouse):
↑ activation of muscle catabolic pathways






↑ blood pressure; proteinuria; endothelial oxidative stress; fetal growth restriction
Lim et al., 2015
PTHrP Low Non-
pregnant
PTHRP knockout PTHrP −/−(mouse):
↓ height; chondrocyte proliferation
↑ premature chondrocyte maturation; bone mineralization
- Lethal at birth




Infusion of PTH/PTHrP receptor antagonist or antibody against PTHrP:
↓ decidual apotosis
↑ decidualization; uterine weight
Vanhouten et al., 2003
Mammary-specific PTHrP deletion (mouse):
↓ blood and milk PTHrP; blood vitamin D; urinary cAMP; bone turnover;
lactation-associated bone loss
↑ bone mass
Williams et al., 1998
Bone-specific PTHrP deletion (mouse):
↑ skeletal fragility
Kirby et al., 2011
High Non-
pregnant
Mammary-specific PTHrP overexpression (mouse):
↓ mammary ductal branching and elongation
Wysolmerski et al., 1995;
Dunbar et al., 2001
Pancreatic β cell-specific PTHrP overexpression (mouse):
↓ diabetogenic effects of streptozotocin; blood glucose
↑ pancreatic islet number and mass; circulating insulin
Vasavada et al., 1996;
Porter et al., 1998
Bone-specific PTHrP overexpression/constitutively active PTHrP receptor
(mouse):
↓ bone ossification, mineralization and length; chondrocyte differentiation
Weir et al., 1996;
Schipani et al., 1997
Kidney-specific PTHrP overexpression (mouse):
↑ renal hypertrophy; urinary albumin excretion
Izquierdo et al., 2006;





↑ mammary gland uptake of calcium, phosphorous, magnesium; milk calcium,
phosphorous, magnesium content
Barlet et al., 1992
Mammary-specific PTHrP overexpression (mouse):
↓ mammary lobuloalveolar and terminal duct development
Wysolmerski et al., 1995
Relaxin Low Non-
pregnant
Relaxin knockout Rln−/− (mouse):
↓ renal smooth muscle cell density
↑ mean arterial pressure; lung function (airway fibrosis and smooth muscle thickening);
heart weight (expression of cardiac hypertrophy associated genes); renal collagen content
Samuel et al., 2003;
Lekgabe et al., 2006;
Debrah et al., 2011;





Relaxin knockout Rln−/− (mouse):
↓ gestational weight gain; lactation; blood sFlt-1; mammary gland development;
reproductive tissue growth and remodeling (e.g., cervix, vagina); litter size
↑ labor length; mean arterial pressure; plasma osmolality; urinary albumin/creatinine ratio;
vascular vasoconstriction; expression of angiogenic markers (Vegfa, Esr1, Pgr, Rxfp1,
Egln1, Hif1a, MMP14, Ankrd37); blood progesterone; mammary duct dilation
Zhao et al., 1999, 2000;
Marshall et al., 2016a,b;
Mirabito Colafella et al.,
2017; O’sullivan et al.,
2017
(Continued)
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TABLE 7 | Continued
Hormones Expression
levels
In vivo effects References
Relaxin receptor knockout RXFP1 −/− (mouse):
↓ mammary gland development; lactation
↑ obstructed delivery; lung fibrosis and collagen accumulation
Kamat et al., 2004;
Krajnc-Franken et al.,
2004
Smooth muscle-specific relaxin receptor RXFP1 deletion (mouse):
↓ cervival and vaginal epithelial development
↑ collagen content in reproductive tract organs and uterine artery
Kaftanovskaya et al.,
2015
Administration of relaxin antibody (rat):
↓ stroke volume; cardiac output; global arterial compliance
↑ systemic vascular resistance




↓ endometrial expression of MMP1 and MMP3; endometrial progesterone production
↑ blood GH and prolactin; endometrial growth; endometrial angiogenesis (endothelial
proliferation and dilatation); uterine weight; endometrial expression of TIMP1, estrogen
receptor alpha; endometrial resident lymphocyte number
Hisaw et al., 1967;
Bethea et al., 1989;
Goldsmith et al., 2004
Exogenous (rat):
↓ systemic and renal vascular resistance; angiotensin-induced renal vasoconstriction;
plasma osmolality; haematocrit; vascular smooth muscle tone
↑ renal plasma flow; glomerular filtration rate; urinary sodium excretion; water intake;
cardiac output; global arterial compliance; uterine artery blood flow velocity
Weisinger et al., 1993;
Danielson et al., 1999;
Conrad et al., 2004;
Vodstrcil et al., 2012
Exogenous (mouse):
↓ cervical and vaginal apoptosis of stroma and epithelium; renal collagen content
↑ decidualization; decidual expression of laminin; cervical and vaginal proliferation of
stroma and epithelium; renal vascular remodeling; renal smooth muscle cell density
Bani et al., 1995; Yao










Bethea et al., 1989
Exogenous (marmoset):
↓ gestation length
↑ uterine expression of estrogen-associated factors; uterine macrophage infiltration;
endometrial angiogenesis; uterine growth; placental growth
Einspanier et al., 2009
Leptin Low Non-
pregnant
Dysfunctional leptin Lepob/ob (mouse):
↓ activity; oxygen consumption; body temperature
↑ food intake; weight; weight gain; adiposity; blood glucose and insulin
Pelleymounter et al.,
1995
Heterozygous for dysfunctional leptin Lepob/+ or leptin receptor Leprdb/+
(mouse):
↑ adiposity; adipose tissue mass




Dysfunctional leptin Lepob/ob (mouse) with pre to mid pregnancy leptin treatment
to initiate pregnancy
↓ lactation; mammary gland development
↑ food intake; gestation length
Chehab et al., 1996;
Mounzih et al., 1998;
Malik et al., 2001
Heterozygous for dysfunctional leptin receptor Leprdb/+ (mouse):
↓ glucose and insulin tolerance; skeletal muscle insulin signaling
↑ food intake; weight gain; GSIS; blood leptin; fasting blood glucose; adipose tissue
mass; hepatic glucose production; fetal weight
↔ fed and fasting blood insulin
Ishizuka et al., 1999;




↓ food intake; blood glucose and insulin
↑ blood pressure; heart rate; oxygen consumption; energy expenditure (brown adipose
thermogenesis)
Scarpace et al., 1997;
Shek et al., 1998
Overexpression (mouse):
↓ time to puberty and menopause onset; liver; white and brown adipose tissue mass;
hepatic glycogen and lipid storage
↑ glucose metabolism; insulin sensitivity (skeletal muscle and hepatic insulin signaling);
blood pressure; sympathetic nervous system activation; urinary catecholamine content
Ogawa et al., 1999;
Aizawa-Abe et al., 2000;
Yura et al., 2000
Exogenous (mouse):
↓ food intake; weight; weight gain; time to puberty onset; blood LH
↑ lean mass percentage; ovarian and uterine weight
Pelleymounter et al.,
1995; Chehab et al.,
1997
(Continued)
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TABLE 7 | Continued
Hormones Expression
levels





↓ food intake; fetal weight
↑ blood pressure; pregnancy-associated rise in blood leptin
Sagawa et al., 2002
Exogenous (mouse):
↓ food intake; weight gain; GSIS; fed blood insulin; fasting blood insulin and leptin;
adipose tissue mass; fetal and placental weights; placental leptin
↑ fed blood glucose
Kulkarni et al., 1997;
Yamashita et al., 2001
Exogenous (rat):
↑ blood pressure; proteinuria; blood markers of endothelial activation (E-selectin and
ICAM-1)
↔ food intake; weight
Ibrahim et al., 2013
cAMP, Cyclic adenosine monophosphate; FSH, Follicle stimulating hormone; GSIS, Glucose-stimulated insulin secretion; ICAM-1, Intercellular adhesion molecule 1; LH, Luteinizing
hormone; MMP, Matrix metalloproteinase; TIMP, Tissue inhibitor of metalloproteinase.
IL-10 by B cells (Fettke et al., 2016). hCG can also modulate
the immune system even in a non-pregnant state, as shown
by its efficacy in preventing the development of autoimmune
diabetes in a mouse model (Khil et al., 2007). In pregnancy,
hCG additionally inhibits the contractile function of smooth
muscle cells in the uterus to help sustain myometrial quiescence
(Ambrus and Rao, 1994; Eta et al., 1994), so as to prevent
premature expulsion of the fetus. Glycosylation of hCG affects
its biological activity and half-life (Fournier et al., 2015). Given
its involvement with multiple systems, it is perhaps unsurprising
that abnormal concentrations of hCG and hCG glycoforms have
been linked with pregnancy complications such as fetal growth
restriction and preeclampsia (Chen et al., 2012). However,
whether the abnormal concentrations of hCG are cause or
consequence of the disorders remains to be determined.
Activins
Activins are members of the TGFβ family and were first
discovered for their role in stimulating FSH production and
determining estrus cyclicity and fertility in mice (Ahn et al.,
2004; Sandoval-Guzmán et al., 2012). Activin signaling promotes
the decidualization, as well as, apoptosis of endometrial stroma
cells (Table 8; Activins; Tessier et al., 2003; Clementi et al., 2013;
Yong et al., 2017); processes that accommodate implantation and
conceptus development (Peng et al., 2015). Additionally, activin
A enhances steroid production, invasion and apoptosis of human
trophoblast in vitro (Ni et al., 2000; Yu et al., 2012; Li et al., 2015).
However, activins may also be of importance in modulating the
physiology of the mother during pregnancy (Table 7; Activins).
In normal human pregnancy, activin A concentrations gradually
rise during gestation and peak at term (Fowler et al., 1998).
The placenta is thought to be the main source of activin A
in the maternal circulation during pregnancy, given the rapid
clearance after delivery of the placenta (Muttukrishna et al.,
1997; Fowler et al., 1998). A similar rise of activin in the
maternal circulation is observed in pregnant ewes (Jenkin et al.,
2001), while the circulating profiles in other species remain
undetermined. Nevertheless, in mice, impaired activin signaling
leads to poor pregnancy outcomes such as fewer viable pups
(Clementi et al., 2013; Peng et al., 2015). However, there is
evidence that an increase in activin may also be pathological
and detrimental to pregnancy outcome. For instance in pregnant
mice, infusion of activin A or plasmid overexpression of activin
A results in the development of a preeclamptic phenotype; dams
display hypertension and proteinuria, in addition to growth
restriction and greater in utero deaths (Kim et al., 2008; Lim
et al., 2015). The maternal hypertension observed likely results
from pathological concentrations of activin A inducing vascular
endothelial dysfunction (Yong et al., 2015). In the non-pregnant
state, activins are also important for renal glomeruli development
(Maeshima et al., 2000), as well as, for bone, fat and muscle
metabolism (Yogosawa et al., 2013; Ding et al., 2017; Goh
et al., 2017). The possible contributions of activin to these latter
functions in pregnancy are currently unclear. Therefore, the
impact of activin signaling on these other body systems during
pregnancy remains to be determined.
Relaxin
Relaxin is a potent vasodilator (Danielson et al., 1999), and
regulates hemodynamics in both the non-pregnant and pregnant
state (Table 7; Relaxin; Conrad et al., 2004). In pregnant women,
circulating relaxin concentration peaks in the first trimester,
declines in the second trimester and is maintained until delivery
in the third trimester (Quagliarello et al., 1979; Seki et al., 1985).
In contrast, circulating relaxin peaks toward term in mice, rats,
guinea pigs and hamsters (O’byrne and Steinetz, 1976; O’byrne
et al., 1976; Renegar and Owens, 2002). In pregnant mice,
relaxin deficiency leads to proteinuria, suggesting a particular
role of relaxin in modulating renal function during pregnancy
(O’sullivan et al., 2017). In addition, relaxin-deficient mice
remain sensitive to vasoconstrictors such as angiotensin and
endothelin, and are hypertensive during pregnancy (Marshall
et al., 2016a; Mirabito Colafella et al., 2017). During pregnancy,
relaxin-deficient mice also display stiffer uterine vessels and fetal
growth is retarded (Gooi et al., 2013). Relaxin also enhances
capillarisation and glucose uptake of skeletal muscles in non-
pregnant mice (Bonner et al., 2013). Taken together, these data
highlight the importance of relaxin in mediating changes in
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TABLE 8 | Effects of additional hormones in vitro.
Hormones Expression
level
In vitro effects References
Activins Low Exogenous low physiological concentrations (human endothelial cells):
↑ proliferation and migration
Yong et al., 2015
Activin receptor ACVR2A siRNA knockdown (human endometrial stromal cells):
↓ decidualization
Yong et al., 2017
Activin receptor knockout ACVR2A−/− (mouse osteoblast cells):
↑ differentiation; mineral deposition; expression of osterix, osteocalcin, and dentin matrix acidic
phosphoprotein 1
Clementi et al., 2013; Goh et al., 2017
High Exogenous (human first trimester and third trimester primary trophoblast, JEG-3 and
HTR-8/SVneo cells):
↓ inhibin secretion
↑ apoptosis; invasion (SNAIL, SLUG, MMP2); hCG production; oxytocin secretion; aromatase
activity (estrogen production); progesterone production
Qu and Thomas, 1993; Steele et al.,
1993; Florio et al., 1996; Song et al.,
1996; Ni et al., 2000; Bearfield et al.,
2005; Jones et al., 2006; Yu et al.,
2012; Li et al., 2014, 2015
Exogenous (mouse placental cells):
↑ differentiation to labyrinth cell fate
↓ growth hormone releasing hormone secretion
Yamaguchi et al., 1995
Exogenous (rat decidual stromal cells):
↑ apoptosis (DNA degradation; caspase 3 activity)
Tessier et al., 2003
Exogenous (human endometrial stromal cells):
↑ decidualisation; production of MMP2, MMP3, MMP7, MMP9
Jones et al., 2006
Exogenous high pathological concentrations (human endothelial cells):
↑ oxidative stress, permeability and endothelin production
Lim et al., 2015; Yong et al., 2015
Exogenous (mouse myoblast cells):
↑ atropy; myofibrillar protein loss; autophagy activation
Ding et al., 2017




Duval et al., 2017




Song et al., 2009
PTHrP antibody or siRNA administration (mouse podocytes):
↓ high glucose induced hypertrophy
Romero et al., 2010
High Exogenous (human third trimester cytotrophoblast cells):
↓ apoptosis
Crocker et al., 2002
Exogenous (rat choriocarcinoma cells):
↑ calcium uptake
Hershberger and Tuan, 1998
Exogenous (mouse ectoplacental cone cells):
↑ trophoblast giant cell differentiation
El-Hashash and Kimber, 2006
Exogenous (human, baboon and rat myometrium):
↓ spontaneous contraction; oxytocin-induced contraction
et al., 1994; Pitera et al., 1998;
Slattery et al., 2001
Exogenous (rat uterine artery):
↑ relaxation
Meziani et al., 2005
Exogenous (mouse podocytes):
↑ high glucose-induced hypertrophy
Romero et al., 2010
Exogenous (human lung epithelial cell):
↓ proliferation
↑ surfactant production
Sasaki et al., 2000
Exogenous (mouse osteoblast):
↑ growth arrest (↓cyclin D1 expression; CDK1 kinase activity)
Datta et al., 2005
Exogenous (rat and mouse vascular smooth muscle cells):
↓ proliferation
Song et al., 2009
hCG Low hCG antibody administration (human third trimester cytrophoblast cells):
↓ syncytiotrophoblast differentiation
Shi et al., 1993
hCG receptor antibody administration (human third trimester cytrophoblast cells):
↑ syncytiotrophoblast differentiation; hCG release (*autocrine, self-stimulatory effects)
Shi et al., 1993
High Exogenous (human trophoblast cells):
↓ leptin secretion
↑ VEGF secretion; adhesion to uterine epithelial cells; invasion; migration; differentiation
Shi et al., 1993; Islami et al., 2003a;
Prast et al., 2008; Lee C. L. et al.,
2013; Chen et al., 2015
(Continued)
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TABLE 8 | Continued
Hormones Expression
level
In vitro effects References
Exogenous (human myometrial strips/smooth muscle cells):
↓ oxytocin-induced contractions; gap junctions (connexin43)
Ambrus and Rao, 1994; Eta et al.,
1994
Exogenous (human endometrial epithelial cells):
↑ VEGF secretion
Berndt et al., 2006
Exogenous (human uterine microvascular/umbilical vein endothelial cells):
↑ proliferation; capillary formation; migration
Zygmunt et al., 2002; Berndt et al.,
2006
Exogenous (rat aorta explant/chicken chorioallantoic membrane):
↑ vessel outgrowth and network complexity
Zygmunt et al., 2002; Berndt et al.,
2006
Exogenous (human uterine natural killer cells):
↑ proliferation
Kane et al., 2009
Exogenous (mouse B cells):
↑ proliferation of specific cell populations; IL10 production; glycosylated antibody synthesis
Fettke et al., 2016
Relaxin Low Relaxin antibody administration (pregnant mouse uterine arteries):
↑ vessel wall stiffness
Vodstrcil et al., 2012
High Exogenous (human first trimester extravillous, third trimester cytotrophoblast and
HTR-8/SVneo cells):
↓ apoptosis (↓caspase 3 and cleaved PARP; ↑BCL2)
↑ proliferation; inflammatory markers (IL6 and IL8); invasive potential (↓TIMP1; ↑MMP2 and
MMP9)
Maruo et al., 2007;
Bryant-Greenwood et al., 2009; Lodhi
et al., 2013; Astuti et al., 2015
Exogenous (human lower uterine segment fibroblast cells):
↑ matrix remodeling (↑MMP1 and MMP3; ↓ TIMP1)
Palejwala et al., 2001
Exogenous (rat uterine artery):
↑ relaxation
Longo et al., 2003
Exogenous (human endometrial/decidual stromal cells):
↑ expression of VEGF, IGFBP1, RXFP1
Unemori et al., 1999; Mazella et al.,
2004
Exogenous (human, pig and rat myometrial strips):
↓ spontaneous contraction Maclennan and Grant, 1991; Longo
et al., 2003
Leptin Low Leptin antisense oligonucleotide (human third trimester placental explants):
↑ immunosuppression (HLA-G)
Barrientos et al., 2015
Leptin antisense oligonucleotide (human JEG-3 and BeWo cytotrophoblast cells):
↑apoptosis
Magariños et al., 2007
High Exogenous (human third trimester placental explants):
↓ apoptosis (caspase 3 activation and p53); triglyceride and cholesterol content
↑ NO production; glycerol release (lipid hydrolysis)
White et al., 2006; Toro et al., 2014
Exogenous (human primary first and third trimester trophoblast, JEG-3 and BeWo
cells):
↓ apoptosis (caspase 3 activation and p53); VEGF, estradiol and progesterone release
↑ proliferation; invasion (MMP2, MMP9 and fetal fibronectin); migration; immunosuppression
(HLA-G); testosterone production; hCG and IL6 release
Castellucci et al., 2000; Cameo et al.,
2003; Islami et al., 2003a; Coya et al.,
2006; Magariños et al., 2007; Liu
et al., 2009; Toro et al., 2014;
Barrientos et al., 2015
Exogenous (mouse trophoblast cells):
↑ invasion; placental lactogen and MMP2
Schulz and Widmaier, 2004; Hughes
et al., 2017
Exogenous (human myometrial smooth muscle cells):
↑ proliferation
Barrichon et al., 2015
Exogenous (human and bovine endothelial cells):
↑ proliferation; migration; tube formation; phosphorylation of transcription factor STAT3
Sierra-Honigmann et al., 1998
Exogenous (human and rat pancreatic islets):
↓ insulin production and secretion
Kulkarni et al., 1997; Seufert et al.,
1999
Exogenous (rat pancreatic β cells):
↑ proliferation
Islam et al., 1997
CASP, Caspase; CDK, Cyclin dependent kinase; HLA, Human leukocyte antigen; MMP, Matrix metalloproteinase; PARP, Poly (ADP-ribose) polymerase; siRNA, short interfering RNA;
TIMP, Tissue inhibitor of metalloproteinase; VEGF, Vascular endothelial growth factor.
maternal vascular function that serve to promote blood flow to
the gravid uterus during pregnancy.
Relaxin may play additional roles within the uterus that
are important for implantation, placentation and pregnancy
maintenance (Tables 7, 8; Relaxin). In vitro, relaxin increases
decidual cell insulin-like growth factor binding protein-1
expression, a marker of decidualization (Mazella et al., 2004).
It also enhances survival and proliferation of cultured human
trophoblast cells (Lodhi et al., 2013; Astuti et al., 2015). During
early mouse pregnancy, relaxin modulates the uterine expression
of genes involved in angiogenesis, steroid hormone action
and remodeling (Marshall et al., 2016b). Indeed in pregnant
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marmosets, exogenous relaxin improves uterine and placental
growth (Einspanier et al., 2009). Relaxin infusion also alters
the endometrial lymphocyte number in vivo (Goldsmith et al.,
2004), which suggests a possible role of relaxin in achieving
immune tolerance of the allogenic conceptus. Relaxin impedes
spontaneous contractility of myometrium in humans, rats and
pigs (Maclennan and Grant, 1991; Longo et al., 2003), and is
thus thought to play a role in regulating the onset of parturition
(Vannuccini et al., 2016). In mice with a deficiency in relaxin
signaling, obstructed deliveries occur at a higher rate due to
poor maturation of the cervix (Zhao et al., 1999; Kamat et al.,
2004; Krajnc-Franken et al., 2004; Kaftanovskaya et al., 2015).
Conversely in hamsters, the rise in circulating relaxin toward
term coincides with cervical ripening in preparation for delivery
(O’byrne et al., 1976). Insufficient relaxin signaling also impedes
mammary development through excessive duct dilation and
reduces the nursing of offspring in mice (Zhao et al., 1999;
Kamat et al., 2004; Krajnc-Franken et al., 2004). Conversely,
overexpression leads to hypertrophy of the nipples in non-
pregnant mice (Feng et al., 2006). Hence, relaxin is important
in driving changes at the maternal-fetal interface that establish
pregnancy, adapts the cardiovascular system of the mother to
support the pregnancy and prepares the mother for lactation
post-partum.
Parathyroid Hormone-Related Protein (PTHrP)
During pregnancy, the placenta serves as an additional source
of PTHrP (Bowden et al., 1994; Emly et al., 1994), a key
hormone involved in bonemetabolism (Table 7; PTHrP). PTHrP
concentrations in the maternal blood rise throughout gestation
in humans (Gallacher et al., 1994; Ardawi et al., 1997; Hirota
et al., 1997) and correlate with the rise in maternal circulating
calcium during pregnancy (Bertelloni et al., 1994). However,
excessively high circulating PTHrP can lead to hypercalcaemia
during pregnancy (Winter and Appelman-Dijkstra, 2017).
PTHrP increases maternal bone resorption, thereby enabling
calcium transfer from mother to fetus for bone development
(Salles, 2016). Thus, it is perhaps not surprising that complete
knockout of PTHrP in mice is lethal at birth in association with
abnormal bone development (Karaplis et al., 1994). Carrying
one defective PTHrP copy is enough to also impede bone
development and reduce snout length in mice (Amizuka et al.,
1996). Mammary-specific PTHrP deletion increases maternal
bone mass and protects against lactation-associated bone loss by
reducing bone turnover inmice (Williams et al., 1998; Vanhouten
et al., 2003). However, deleting bone-specific PTHrP increases
skeletal fragility, both in the non-pregnant and pregnant state
(Kirby et al., 2011). PTHrP infusion of lactating goats increases
mammary gland uptake calcium, phosphorous and magnesium
for transfer in milk to the neonate (Barlet et al., 1992). These
findings imply that a fine balance of PTHrP production by
gestational andmaternal tissues must be achieved for appropriate
regulation of maternal bone metabolism and offspring calcium
requirements during pregnancy and lactation.
Placental-derived PTHrP may also exert additional effects on
the placenta and the mother which are beneficial for offspring
development and growth. PTHrP stimulates the proliferation,
differentiation, outgrowth and calcium uptake of trophoblast
in vitro (Table 8; PTHrP; Hershberger and Tuan, 1998; El-
Hashash and Kimber, 2006). In vivo, blocking PTHrP signaling
during mouse pregnancy leads to excessive uterine growth
and decidualization in association with a decrease in decidual
cell apoptosis (Williams et al., 1998; Vanhouten et al., 2003).
Moreover, over-expression of PTHrP impairs mammary gland
branching morphogenesis (Wysolmerski et al., 1995; Dunbar
et al., 2001). These studies highlight a possible important
regulatory role of PTHrP in the control of decidualization and
mammary gland development in vivo. In non-pregnant mice,
PTHrP enhances pancreatic β-cells proliferation and insulin
secretion whilst it inhibits islet cell apoptosis (Vasavada et al.,
1996; Porter et al., 1998; Cebrian et al., 2002; Fujinaka et al., 2004).
It also increases renal plasma flow and glomerular filtration
rate, and exerts proliferative effects on renal glomerular and
tubule cells in rodents (Izquierdo et al., 2006; Romero et al.,
2010). Additionally, in vitro studies show PTHrP can induce
relaxation of uterine arteries (Meziani et al., 2005). However, the
significance of PTHrP on glucose-insulin dynamics and renal and
vascular function of the mother during pregnancy remains to be
investigated.
Leptin
Leptin is an abundant circulating hormone involved in regulating
appetite. In the non-pregnant state, the adipose tissue is the
exclusive source of circulating leptin. During pregnancy in
humans, baboons and mice, concentrations of leptin rapidly
rise throughout gestation, peaking toward term (Highman et al.,
1998; Henson et al., 1999; Malik et al., 2005). The rise in
leptin positively correlates with increases in maternal body
fat (Highman et al., 1998). In humans, blood leptin rapidly
falls to non-pregnant concentrations within 24 h of delivery,
indicating that the placenta contributes to the main rise of
leptin in pregnancy (Masuzaki et al., 1997). In particular,
leptin is produced by the human placental trophoblast cells
(Masuzaki et al., 1997). A similar post-pregnancy decline and
placental trophoblast expression is seen in baboons (Henson
et al., 1999). However, this is not the case for mice, as the
murine placenta does not produce leptin (Malik et al., 2005).
Nevertheless, leptin studies inmice still provide useful knowledge
about pregnancy-related effects of leptin (Table 7; Leptin). For
instance, leptin in pregnancy helps prepare the mother for
lactation, as a deficiency results in impaired mammary gland
development, which is detrimental for lactation post-delivery
(Mounzih et al., 1998; Malik et al., 2001). Another significant
effect of leptin in pregnancy observed through mouse studies
is leptin resistance, whereby the dam increases her food intake
in mid-pregnancy to meet increased energy demands despite an
increase in circulating leptin, which in the non-pregnant state
would lead to satiety (Mounzih et al., 1998). In contrast, excessive
leptin significantly decreases maternal food intake and restricts
feto-placental growth (Yamashita et al., 2001). Leptin exposure of
rat and human islets and cultured insulinoma cells significantly
decreases insulin production in vitro, demonstrating that leptin
may be directly involved in glucose metabolism (Table 8; Leptin;
Kulkarni et al., 1997). Indeed dysfunctional leptin signaling in
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FIGURE 2 | Summary of expression profiles, interactions and maternal physiological effects of placental-derived hormones. PRL, prolactin; PL, placental lactogen;
PLF, proliferins; PRP, proliferin-related proteins; GH, growth hormone; GHRH, growth hormone releasing hormone; IGF1/2, insulin-like growth factor-1/2; E2, estrogen;
P4, progesterone; MEL, melatonin; SER, serotonin; KISS, kisspeptin; OXY, Oxytocin; TRH, thyrotropin-releasing hormone; RELAX, relaxin; ACTIV, activin; CG,
chorionic gonadotropin; LEP, leptin; PTHrP, parathyroid hormone-related protein.
pregnancy leads to the spontaneous development of a gestational
diabetic phenotype in db/+ mice, who are heterozygous for
the leptin receptor (Table 7; Leptin; Yamashita et al., 2001).
Further in vitro studies on placental explants or trophoblast
cultures highlight a potential for leptin to be involved in
immune modulation and placental hormone production, given
its stimulatory effects on HLA-G and hCG expression (Table 8;
Leptin; Chardonnens et al., 1999; Islami et al., 2003a,b; Barrientos
et al., 2015). Additional effects of leptin on the placenta are
thoroughly reviewed elsewhere (Schanton et al., 2018). Therefore,
placental leptin can have systemic effects on the mother in
pregnancy.
CONCLUSION
Pregnancy represents a unique physiological paradigm; there are
dynamic and reversible changes in the function of many organ
systems in the mother that are designed to support offspring
development. In part, these changes are signaled via the placental
secretion of hormones, which in turn, alter in abundance, interact
with one another and exert wide effects on maternal tissues
during pregnancy. For instance, steroid hormones modulate
most systems of the mother throughout pregnancy. However,
they also alter the production of other hormones, such as
prolactin and placental lactogens, which in turn, may contribute
to the physiological changes in the mother (Figure 2). However,
further work is required to better define how placental hormones
elicit their actions in the mother, as well as, identify the extent
to which they interplay with hormones produced by maternal
tissues. As the endocrine and metabolic state of the mother is
also influenced by her environment, maternal conditions such
as poor nutrition and obesity may modulate placental hormone
production and pregnancy adaptations. Indeed, previous work
has shown that an obesogenic diet during pregnancy alters
the expression of PRL/PL genes in the placenta in association
with mal-adaptations of maternal metabolism in mice (Musial
et al., 2017). Further studies are nonetheless needed to assess
the interaction of the maternal environment with placental
endocrine function. Placental hormones are also released into
the fetal circulation, where they may have direct impacts on
fetal growth and development (Freemark, 2010). Investigations
exploring the importance of placental endocrine function on
fetal growth, independent of the mother, will require future
examination. Collectively, further studies on the nature and
role of placental endocrine function in maternal adaptations
and fetal growth will undoubtedly provide novel insights into
understanding of the potential causes of obstetrical syndromes
such as gestational diabetes and preeclampsia that are marked by
maternal physiological maladaptation.
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